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Abstract 
The present work focuses on the development of new bioinformatics tools to assist the 
user in a Computational Chemistry/Theoretical Chemistry laboratory, improving the 
Computer Aided Drug Design process. Often the use of already existing software requires a 
slow learning process, where simple tasks can reveal tricky to the non-expert users. As a 
consequence, interfaces were developed here too that make simple the task of the user. 
 
 An outline on Computer Aided Drug Design is given in the first chapter, highlighting the 
drug development cost and listing the subjects proposed to be developed and improved. In 
the second chapter, the theory behind the present work is described, focusing on the theory 
on which the pre-existing used software are based. 
 
The remaining chapters refer to the developed work in these last four years, both already 
published and unpublished, being each chapter devoted to each developed software. The 
subjects covered in each chapter are: virtual screening and the developed software vsLab; 
chemical motifs inside protein structures and the software Chem-Path-Tracker; structural 
surfaces and volumes calculated by the software VolArea; and last the Computational 
Alanine Scanning Mutagenesis technique to study protein-protein interactions performed by 
the software CompASM. 
 
All developed software are plug-ins of the world wide used molecular visualizer, Visual 
Molecular Dynamics (VMD). This association revealed very interesting and useful because it 
was possible to provide the software with the visual dimension, thus complementing the 
numerical results returned by the developed tools. In this way it is given to the user the 
possibility to inspect the results visually, which is crucial in most of the times to improve the 
quality of the conclusions to be retrieved. 
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Resumo 
O trabalho presente nesta tese consiste no desenvolvimento de novas ferramentas 
bioinformáticas que visam auxiliar o utilizador num laboratório de Química 
Computacional/Química Teórica melhorando, assim, o processo de design de fármacos 
baseadas em estudos computacionais. A necessidade deste auxílio revela-se importante 
aquando da utilização de vários programas informáticos afetos a esta área. Por vezes a 
simples utilização de um programa informático exige uma curva de aprendizagem lenta, 
onde nem sempre a mais trivial operação é de fácil execução para os utilizadores mais 
inexperientes. 
 
No primeiro capítulo é dada uma visão geral da temática do design de fármacos por 
meios computacionais, realçando a problemática dos custos associados a este tema, 
apresentando os pontos propostos a serem desenvolvidos e melhorados. No segundo 
capítulo é descrita a teoria que serve de base às ferramentas informáticas já existentes que 
foram utilizadas para o desenvolvimento deste trabalho. 
 
Os restante capítulos são referentes ao trabalho desenvolvido no decorrer destes últimos 
quatro anos, publicados ou por publicar, sendo cada capítulo afeto a uma ferramenta 
informática. Os temas referentes a cada capítulo são: virtual screening e a ferramenta 
desenvolvida vsLab; padrões químicos contidos em estruturas proteicas e o programa 
Chem-Path-Tracker; cálculo de superfícies e volumes de estruturas realizado pelo programa 
VolArea; e por último a técnica computacional de mutagénese por alaninas para o estudo de 
interações proteína-proteína realizada pelo programa CompASM.      
 
Todos os programas foram embutidos num programa de visualização molecular 
mundialmente utilizado denominado Visual Molecular Visualizer (VMD). Esta associação 
revelou-se bastante interessante e útil, pois foi possível dotar os programas da dimensão 
visual, complementando assim os resultados numéricos originados pelas ferramentas 
desenvolvidas. Assim é dada a possibilidade ao utilizador de inspecionar visualmente os 
resultados, muitas vezes crucial para melhorar a qualidade das conclusões a serem 
retiradas.  
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Résumé 
Le présent travail se concentre sur le développement de nouveaux outils bioinformatiques 
pour aider l'utilisateur dans un laboratoire informatique Chimie / Chimie théorique, 
l'amélioration de la Assistée par Ordinateur processus Drug Design. Souvent, l'utilisation 
d'un logiciel déjà existant nécessite un processus d'apprentissage lent, où les tâches simples 
peuvent révéler difficile pour les utilisateurs non - experts. En conséquence, les interfaces 
ont été développés qui font ici aussi simple, la tâche de l'utilisateur. 
 
Un aperçu sur Conception Assistée par Ordinateur drogue est donnée dans le premier 
chapitre, en soulignant le coût de développement de médicaments et la liste des sujets 
proposés pour être développé et amélioré. Dans le deuxième chapitre, la théorie derrière ce 
travail est décrit, en se concentrant sur la théorie sur laquelle sont basées les logiciels 
utilisés pré-existant. 
 
Les chapitres se réfèrent au travail développé dans ces quatre dernières années, tous deux 
déjà publiés et non publiés, étant chaque chapitre consacré à chaque logiciel développé. Les 
sujets abordés dans chaque chapitre sont : le criblage virtuel et le vsLab logiciel développé ; 
motifs chimiques à l'intérieur des structures de protéines et le logiciel Chem -Path -Tracker , 
les surfaces et les volumes calculés par le VolArea logiciel structurelles et durent la 
technique informatique Alanine Scanning mutagenèse à étudier interactions protéine-
protéine exécutées par le logiciel CompASM . 
 
Tous les logiciels développés sont les plug-ins du monde de visualiseur large utilisé 
moléculaire, Visual Molecular Dynamics (VMD). Cette association a révélé très intéressant et 
utile, car il était possible de fournir le logiciel avec la dimension visuelle, complétant ainsi les 
résultats numériques retournées par les outils développés. De cette manière, il est donné à 
l'utilisateur la possibilité d'inspecter visuellement les résultats, ce qui est essentiel dans la 
plupart des fois d'améliorer la qualité des conclusions à récupérer. 
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1. Introduction 
The discovery of new therapeutic compounds and the improvement of existing drugs are 
crucial aspects for every modern society, especially for rational drug design where the time 
and the costs of the process must be controlled and environmental harmless procedures 
must be taken. Despite some divergences in terms of the real cost of drug design1-4, some 
authors suggested that it is necessary more than 8 years and millions of dollars (between 
800 and 2000 million US dollars) to develop a new therapeutic compound. These predictions 
are based in the probability of the new drug successfully pass each clinical trial phase. Here, 
the primordial steps of the drug design are extremely important to improve these 
probabilities, mainly when computational means are efficiently used.   
Independently of the chosen methodology to develop a new drug, crucial steps are 
required, such as the identification of hit compounds and improvement of the lead 
compounds; the correct study and description of the drug target, and the prediction of the 
effects of the drug in terms of absorption, metabolism, excretion and toxicity (AMDE/Tox). 
Despite the possibility of performing these steps in vitro, it is using computational tools where 
major gains are obtained. 
Computer-Aided Drug Design (CADD) is a field of research that comprehends a vast 
collection of computational solutions to store, manage, analyze and model chemical 
compounds. Here, the main purpose is to simulate ligand-receptor complexes in biological 
conditions in order to predict chemical properties to anticipate and manipulate drugs 
functionality and behavior. One of the greatest advantages of a CADD campaign is the 
possibility to select or model the potential compounds; calculate the drug-receptor binding 
properties and optimize compounds in silico, avoiding the usage and production of harmful 
substances. Only then, the most promising compounds are experimentally synthetized and 
tested improving the success and speed, i.e. reducing the costs of drug discovery.  
The bases of the new potential drug commonly derive from one or more databases 
containing a massive number of molecules, which is the case of the ZINC database 5 
(despite the name it is not a Zinc based compound database). This free repository in 
particular contains about 21 million compounds prepared for virtual screening in their 
biologically relevant forms. Besides the atoms’ 3D-coordinates, this database contains the 
values that describe the residues protonation states, molecular weights, calculated LogP and 
the rotatable bonds, making ZINC database an important source for CADD campaigns. 
Beside this repository, there are many other repositories containing a large number of 
structures as well, which is the case of Available Chemical Directory (ACD, over 7 million 
compounds)6, National Cancer Institute compound database (NCI, over 260 000 
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compounds)7 among others 8-10, in which some of them unfortunately are not so completed in 
terms of biological significant values. 
One keystone of the drug design process is the full characterization of the target structure, 
even before the selection of the possible candidates from the previous mentioned databases. 
Generally, these structures are obtained from experimental means and stored in the Protein 
Data Bank (PDB) 11,12. This database is composed by the structures of large biological 
molecules, such as proteins and nucleic acids, mainly resolved by X-Ray 
Crystallography/Diffraction and Nuclear Magnetic Resonance (NMR). However, when the 
experimental 3D-structure is not available, the most reliable technique to use is Homology 
Modelling 13-15 or to extract the structure from the homology based, Homology-derived 
Secondary Structure of Proteins(HSPP) database 16,17. 
The availability of such amount of information is a vital aspect for computational chemists 
allowing the application of CADD techniques in a wide variety of biological processes, using 
appropriate and successfully proven methodologies such as molecular docking18 and virtual 
screening19. CADD methodologies have been supported by the appearance of numerous 
scientific software focused on drug design or molecular simulations, serving different 
purposes, presenting more or less accurate results, freely available or purchasable 20-24. The 
development of efficient parallel algorithms has boosted CADD even further, and lately the 
usage of Graphics Processing Units (GPU) in massive parallel operations 25 has resulted in 
significant gains in terms of speed and allowed size of the simulated systems. On the other 
hand, large collections of structures and software specialization can also bring difficulties and 
challenges to the researcher in his/her projects. Here, bioinformatics play an important role 
creating tools to complement existing software, turning all this information usable and 
manageable. Using these tools is possible to extract significant and relevant values, 
improving in this way the efficiency of CADD campaigns.  
Examples of such demand for process optimization in CADD methods is felt, for instance, 
when it is necessary to evaluate the binding of a large set of compounds extracted from one 
of the previously mentioned databases. It is thus necessary to analyze the poses of those 
structures against the target’s binding site and rank the ligands regarding the strength of 
binding interactions or other parameters. The information required to perform this process 
would be impossible to handle manually, and even computationally users would have to be 
familiar with programming languages such as Python or Tool Command Language (TCL). 
For instance, at the end of a protein-ligand docking calculation, the total number of files 
originated by the software can easily double or quadruple the number of structures files (e.g. 
using Autodock26), making the extraction of the information of interest laborious and 
hardworking. The same exponential growth of generated information can occur when another 
CADD technique is applied, namely Computational Alanine Scanning Mutagenesis 
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(CompASM)27. This method analyzes protein-protein interfaces, identifying the residues that 
contribute more for the binding of the intervening systems. CompASM is based on the 
premise that residues responsible for the binding of the proteins (hotspots) cause significant 
variations in the binding energy of the complex when mutated by an alanine residue28. 
Moreira et al. proposed a successful protocol for a computational application of ASM which 
comprehends Molecular Dynamics (MD) simulations and Molecular Mechanics/Poisson-
Boltzmann Surface Area (MMPBSA)29 calculations.  
Despite the major improvements in protein-ligand docking, virtual screening and ASM 
methods, several developments are required in order to bring this analysis to general use 
and to non-expert users. These new tools must have the ability to assist the user in the 
generation and parameterization of the input data and assemble the final results, displaying 
them in a user-friendly manner. 
The work presented in this thesis provides solutions to assist computational chemists in 
their daily work, developing new tools to simplify the application of Molecular Docking, Virtual 
Screening, and Computational Alanine Scanning Mutagenesis, applying world-wide used 
software such as AutoDock26, and the Amber molecular simulation package30. In this chapter 
new algorithms are described to calculate protein structural features, namely surface 
residues in contact with solvent or other compounds, as well as to calculate the volume of 
any structure and empty spaces such as cavities and clefts. It is also presented a 
bioinformatics tool to identify and track chemical motifs (hydrogen bonds, cation-π-
interactions, proton-electron transfer pathways and water tunnels) throughout a 
protein/molecular system. In order to provide a visual aspect to the user, allowing the 
inspection of the results, the developed tools are compatible with the widely used molecular 
visualizer, Visual Molecular Dynamics (VMD)31. 
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2. Methods 
This section intends to give an overview of the theoretical methods applied in the 
developed work, in order to provide the foundations of the software used in the presenting 
new bioinformatics tools. The covered subjects are: Molecular Mechanics, Molecular 
Dynamics highlighting the specific binding energy calculation method Molecular 
Mechanics/Poisson-Boltzmann Surface Area (MMPBSA); and Molecular Docking, in 
particular Protein-Ligand Docking and Virtual Screening. In each topic, the theoretical 
contents associated to each subject is described numbering the most used software. A full 
method description and deeper understanding of computational chemistry is presented in 32. 
2.1. Molecular Mechanics  
2.1.1.   Introduction 
Molecular mechanics (MM) is a simplification of the molecular structure model to an 
aggregated complex of “balls and springs”, where the unitary particle is the atom, neglecting 
electrons and protons as individual particles. In MM methods, the information assigned to 
each particle (atom) is the atomic mass, charge, van der Waals radii and instead of 
calculating the bonding information as a product of the Schrödinger equation, the values for 
bond lengths, bond angles and dihedral angles are provided explicitly as parameters of the 
force field. Since the first published paper applying molecular mechanics calculations33, 
several works have been published using this method with very interesting and promising 
results27,34-38. The application of this method to biomolecules has got great acceptance 
mainly because of the relative good performances in terms of speed and final results. Other 
important factor that contributed to the generalization usage of these methods were the 
increase of the community users that have applied these tools through these last decades, 
making somewhat easy to obtain the parameters for a wide range of structures type. At the 
same time, the requirement for these parameters is one of the drawbacks of this 
methodology, which are not always available, requiring its calculation. This method also fails 
when a deeper understanding of the system is intended, for instance, the study of formation 
and breaking of the chemical bonds.    
In spite of the negative aspects, MM methods are still a very powerful strategy for 
molecular simulations and drug design. For instance, it is now possible to simulate 1 million 
atoms model of the satellite tobacco mosaic virus with a simulated time of 50 nanoseconds 
(ns) 39. The application of these methodologies is quite straightforward while the type of 
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atoms in the system remains common or is possible to obtain the parameters from other user 
calculations. In both cases, MM packages such AMBER40, CHARMM41, GROMACS42 
incorporate a large source of parameters for a wide range of biological molecules, such as 
amino acids and nucleotides, and have a large community of users. This last factor increases 
the probabilities of finding some missing parameters, allowing the simulation of a wide range 
types of systems.  
2.1.2.  The Force Field Energy  
Molecular Mechanics describes the force field energy (!!!) as the sum of the terms 
describing the energy required to distort a molecule in a specific way: 
 
 
This equation is composed by energy functions that deal with bond interactions, non-
bound interactions and cross-terms, being the first three terms the stretching energy (!!"#), 
the bending energy (!!"#$ ) and the torsional energy (!!"# ) functions to describe the 
interactions between bonded atoms; the following two are the van der Waals (!!"#) and 
electrostatic energy (!!"!) functions to describe the unbound interactions, and the last term of 
the equation is the combination of the any of the  previous terms.  
 
Figure 1- Terms of the Force Field Energy function. 
The differences in the composition and complexity of the equations adopted to calculate 
these energies are mainly determined by the problem to be solved by the different force 
fields. For instance, the AMBER force field aims at dealing with biological systems, which 
can easily turn very computationally demanding due to the size of the complexes. In this 
 !!! = !!!"# + !!!"#$ + !!"# + !!"# + !!"! + !!"#$$! (1)  
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case simplified functions are required, describing only the bond and non-bond terms, 
dismissing the description of the out-of-the-plane bending energy and the cross-term. All 
molecular simulations presented in this work were carried out using the AMBER force field, 
and only the terms contained in this force field will be described in the following sections.  
2.1.2.1.  The Stretching Energy 
!!"# is the function of the energy associated to the elongation of the bond between two 
atoms (A and B) around the equilibrium bond length. A simple way to calculate this value is 
by the harmonic potential presented in equation (2). 
 
 
In equation (2) !!"  defines the bond force constant and !!!"  defines the equilibrium 
bond length between atoms A and B. Despite the good results obtained by this potential in 
equilibrium geometries, a more accurate solution is required to analyze long-range bond 
distance or when it is necessary to include additional energy terms such as vibration 
energies.  
The Taylor expansion of the harmonic potential up to the fourth term in equation (3) is a 
better energy descriptor when it is necessary to analyze these energies beyond the 
equilibrium bond length.   
 
In spite of the better result, this expansion still presents two major drawbacks: the first one 
is the requirement of more parameters to be assigned, and the second one is the tendency 
to infinity (+∞) in long bond lengths, instead of a tendency to a constant energy, the 
dissociation energy. 
The most accurate method to calculate the stretching energy is through the Morse 
potential (4), unfortunately this method is also the most slow/computationally demanding 
method.  
 
 !!"# !!" = !!" !!" − !!!!" ! = !!!" ∆!!" !! (2)  
 !!"# !!" = !!!" ∆!!" ! + !!!!" ∆!!" ! + !!!!" ∆!!" !! (3)  
 
!!"#$% ∆! = !(1 − !!!∆!)!!
! = !2!! (4)  
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Like the previous potential, this method also requires some parameters such as the 
dissociation energy ! and the force constant at the equilibrium distance !.  
 
  
Figure 2- The stretching energy of the C-H bond of the CH4 molecule. The exact curve was based on an electronic 
structure calculation with CASSCF/6-311++G(2df,2dp), the P2 and P4 curve stands for the simple harmonic 
potential and the Taylor Expansion of the harmonic potential, respectively 32. 
At ambient or biological temperature, the bond length usually presents a variation of 
0.03Å and the curve region of interest for simulation purposes is the bottom energy ~40 
kJ/mol. In this region, all methods present close results, differing only in the computational 
and parameters requirements. In this case, the simple harmonic potential does not introduce 
significant errors, being profitable mainly by the calculation speed. The force field used in this 
work, AMBER force field, implemented the harmonic potential as the elected method to 
calculate stretching energies. 
2.1.2.2. The Bending Energy  
The !!"#$ energy function describes the energy necessary to change the angle formed by 
three atoms A-B-C, centered on atom B. Just like in the previous term, the bending energy is 
efficiently described by the simple harmonic potential (5). This potential formulation also 
requires the parameterization of the force constant !!"# and instead of the equilibrium bond 
length !!!", here it is required the value of the equilibrium bond angle !!!"#. 
 
 !!"# !!"# = !!"# !!"# − !!!!"# ! = !!!"# ∆!!"# !! (5)  
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If a more accurate solution is required, the third term of the Taylor expansion returns a 
reasonable value, which is not normally necessary as it is possible to see in Figure 3.  
 
Figure 3- The bending energy of the H-C-H angle of the CH4 molecule. The exact curve was based on an electronic 
structure calculation with (MP2/aug-cc-pVTZ), the P2 and P3 curve stands for the simple harmonic potential and the 
Taylor Expansion of the harmonic potential, respectively 32. 
 
 
As mentioned previously, at the bottom 40 kJ/mol energy of the curve (equivalent to most 
hydrogen bond energies), both methods fit reasonably well to the energy curve, being the 
simple harmonic potential more efficiently computed mainly due to the requirement of only 
two parameters.  
2.1.2.3. The Torsional Energy  
!!"# (torsional energy) is the energy necessary to rotate atoms A or D around bond B-C in 
a sequence of bonded atoms A-B-C-D (Figure 4). 
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Figure 4- Illustration of the torsional angle definition. 
Unlike the !!"# and !!"#$ functions, the harmonic potential is not the perfect solution to 
calculate the torsional energy mainly by the absence of descriptors for two observed 
behaviors in this type of distortion: one is the periodic movements allowed when the atoms 
are rotated in turn of the central bond, and the other is the low energy requirement to 
alternate between different minima.  
To incorporate the missing aspects, a Fourier series (6) is used instead of the harmonic 
potential. 
 
The periodicity of this function is acquired by the ! term, which provides to each period nth 
rotation angles: ! = 1 term describes a 360º periodicity, ! = 2 describes a period in each 
180º, ! = 3 term determines periodicity in each 120º, and so on. The !! constant is the size 
of the barrier of the rotation around the B-C bond. The ! factor, the division by 2 and the 
summation of 1 are operations necessary to produce standard outputs so the values 
returned by this equation may have a user defined minimum at 180º, and the !!"#/ !! values 
vary between one and zero. 
2.1.2.4. The Van Der Waals Energy  
The van der Waals (E!"#) energy function term is the first descriptor for the non-bonded 
atoms interactions. This term is correlated with the non-polar interaction between the atoms, 
describing the attraction and repulsion provoked by the electron clouds surrounding the 
nuclei. This physical property explains the energy variation, in which at very small distances, 
 !!"# !!"#$ = !!!! !!!"#$2 [1 + !"# !!!"#$ − !! ]! (6)  
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the E!"#  energy becomes positive, reflecting the repulsion forced by the overlap of the 
electron clouds. At median distances, about 3.5 Å, this energy becomes slightly negative 
(attractive) due to the induced dipole-dipole forces, tending to zero at very long distances, a 
R-6 dependency, being R the distances between the two atoms.  
 The Lennard-Jones potential (7) reflects the behavior described above, presenting 
two parameters, the van der Waals radius !! and the softness factor (!).  
The 12 exponential factor of the repulsive fraction of the equation is not related with 
physical evidences or theoretical basis, in which the values 9 or 10 returned better results. 
The usage of this factor is only associated with computational intrinsic features, which are 
calculated by squaring the attractive fraction with the exponential factor 6. 
 If a better descriptor is required, it is possible to calculate this energy using two 
different potentials: on is the “Buckingham” or “Exponential R-6” potential (8), and the other 
one is the Morse potential. In the first potential, A B and C factors are constants and the !!" 
is the distance between the atom A and B.  
Despite the better accuracy of this potential, its usage can also constitute a source of 
error, especially at very small distances, where the (!!")!! tends to −∞ creating a “nuclear 
fusion”, instead of becoming a positive repulsive energy. The Morse potential increases the 
accuracy of the results in all circumstances, but it also increases the computational time 
necessary to calculate these interactions like explained before. 
The non-bonded atom interactions require special attention in terms of the computational 
time requirements. This problem becomes even more important in biological systems, since 
they contain a large number of atoms. While the number of bonded interactions increase 
linearly with the number of the atoms, the non-bonded interactions grow as the square of the 
system’s size, turning the calculations of these energies the predominant procedure in the 
force field energy calculation.  
To reduce the calculation time of the non-bonded energies, one or more cut-off distances 
can be applied. In the case of one cut-off distance, in which the van der Waals energy 
becomes zero at great distances, the potential becomes a discontinuous descriptor. To solve 
this problem, a two cut-off distance approach can be adopted, in which a smothering function 
is applied between the two distances values, where the energy slowly tends to zero between 
these two energies. 
 
 !!" !!" = !4! !!!"!!" !" − ! !!!"!!" ! ! (7)  
 !!"# !!" = !!!!!!" − ! !(!!")!! (8)  
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2.1.2.5. The Electrostatic Energy  
The electrostatic energy (E!"!) term of the force field energy equation is the second non-
bond interaction descriptor. This term describes the electrostatic interactions between the 
average point charges of the atoms in the system and it is calculated based on the Coulomb 
potential (9).    
In this potential, !! and !! are the charges of the correspondent atoms A and B, !!" is 
the distance between them and ! is the dielectric constant of the medium. The dielectric ! 
can be parameterized to simulate the electronic environment of the system, such as ! = 1 for 
vacuum, or higher values; for instance ! = 4 for proteins and ! = 80 for water, simulating the 
water as the solvent in the absence of explicit water molecules.  
In a physical sense, the atom point charge is not fully correct, being adopted as the point 
that describes better the arrangement of the electric field around the atom. This concept is 
applied in the AMBER force field through the Restrained ElectroStatic Potential fit (RESP). 
The E!"!  energy describes not only the influence of the formal charged atoms in the 
system, just like the oxygen atom in a hydroxide molecule, but also the partial charged 
atoms. Here, dipole-dipole interactions and hydrogen bonds are also implicitly included. For 
instance, an alcohol oxygen atom partially negatively charged would have the tendency to 
interact favorably with a partially positively charged hydrogen atom from another alcohol 
group. One of the most severe limitations of molecular mechanics is related to this function, 
in which the surrounding atom environment has no influence in the point charges of the 
atoms, keeping their charges static through the simulation calculation. 
2.1.2.6. The Force Field Parameterization 
Besides the importance of the equations choice to describe the different terms of the force 
field, the efficient and accurate parameterization of the constants in the equation also plays a 
central role in the molecular mechanics methods. In spite of no force field parameterization 
having been performed in this work, this subject has a relevant importance in molecular 
simulations. 
For an ordinary structure such as proteins, most of the parameters are included in the 
molecular simulations packages. However, this is not the case for most substrates or 
inhibitors, in which the calculation of parameters like the stretching energy constant force K!", or the torsional barrier size, is required. This last term is problematic due to the number 
of possibilities.  
 !!"! !!" = !!!!!!!!" ! (9)  
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There are two ways for a computational chemist to obtain values for these parameters: 
one is deriving them from experimental values, but we are always conditioned by their 
availability, and the other option is by computational means, which are relatively easier, 
cheaper and straightforward to apply. Here, sophisticated computational methods such as 
Density Functional Theory (DFT) or post Hartree-Fock methods can be applied. In the case 
of the stretching energy, the parameters can be obtained by structure optimization and 
posterior scan, where the bond length is stretched and shrunken until the equilibrium value is 
reached. Later, this data is fitted to the harmonic potential or other potential. 
The van der Waals parameters are normally assigned to single atoms directly from the 
experimental data, and later combined for the diatomic value. The simplest approach is to 
calculate the diatomic van der Waals distance as the sum of the two van der Waals radii, and 
the softness factor as the geometrical mean of the atomic softness constants. 
As mentioned above, the charge parameter should describe the electrostatic field 
surrounding the atom, instead of a group of single point charges. These charges are 
calculated by the electrostatic potential of a series of points in a grid around the desired 
molecule, and adapted later to single points that reproduce better those values. 
2.1.3. Molecular Dynamics   
 
One of the most relevant applications of the molecular mechanics principles is in the 
description of the trajectories of the atomic structures throughout time. Here, Molecular 
Dynamics (MD) simulations describe the atoms’ Cartesian coordinates that have suffered the 
influences of the other atoms. The movements of the atoms are simulated by solving 
Newton’s second equation, ! = !", in order to obtain a time dependent descriptor (10). 
The previous equation describes the trajectory of particle !  with mass !!  along one 
coordinate !! with !!! representing the force acting on the particle in that particular direction. 
This force is calculated based on the potential energy obtained from the terms described in 
the earlier sections. This mobility description is deterministic, meaning that for any value of 
time variable, the state of the system can be calculated once the position and the velocities 
are deduced.  
In Molecular simulations, this function is applied by the Newton’s equation as a function of 
3N coordinates (i.e. the 3D spatial location). The complexity of the systems usually analyzed 
by this function turns the analytical solution impossible, requiring therefore the numerical 
 
!!!!!"! = !− !!!!! ! (10)  
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resolution of the equations. To do so is necessary to define a finite integration step 
denominated simulation time step (!").  
2.1.3.1. Simulation Time Step 
The proper parameterization of the integration step requires special care that will 
determine the right description of molecular behavior. This time step must be set as a 
function of the quickest motion period to be described, and at the same time, the value that 
returns a relative economy in terms of computational demand and time consumption. The 
wrong parameterization of this value can lead to a mismatched description of the atoms 
trajectories due to the abrupt variation of the potential energy, or a software breakdown due 
to the numerical overflow.     
The common rule applied to choose this value is the calculation of the number that is at 
least one order of magnitude smaller compared to the highest-frequency vibration motion in 
biological structures. This motion is the bond stretching movement involving hydrogen atoms, 
which is around 10 fs (e.g. the C-H bond stretching), originating an integration step of 1 fs. 
Despite of the fact that C-H bond stretching is the fastest motion period, its influence in terms 
of the potential energy variation is not significant, and the respective fluctuations do not 
imprint a significant numerical instability, giving space to restrain their variation and therefore 
save computational time. To perform these constrains, the SHAKE algorithm 43 is usually 
applied, in which the bonds containing hydrogen atoms are frozen to their equilibrium values, 
and the highest-frequency vibrations in the system are now the bonds stretching between 
heavy atoms such as the C-C bond. These frequencies have a motion period between 2 and 
5 times slower (20 to 50 fs) than the hydrogen intervenient bonds, which is translated in a 
suggested time step of 2 fs. 
2.1.3.2. Simulation Time Scale 
Besides the integration step, there is another time variable, which is the time simulation. 
This time scale defines the time range in which the atoms trajectories will be simulated. The 
value of this variable is related to the kind of structural motions that is intended to observe. 
For instance, if only the atoms position fluctuations or side chains motions are intended to 
simulate, the time range necessary to observe these variations is in the order of 
picoseconds.  On the other hand, loop motions can take several nanoseconds, a protein 
subunit motion or even the folding and unfolding of protein could be out of the scope of this 
method. The choice of these values can also be influenced by the size of the system. Here, 
the total cost in terms of computational time can be very high. The values of time scale that 
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establish a good commitment between the computational time (real time) and the quality of 
the simulated trajectory are in the range of the hundreds of nanoseconds for the enzymatic 
systems.  
2.1.3.3. Boundary Conditions  
In biological environment, it is possible to admit that a molecule is immersed in infinite 
universe, or has infinite space around it in all directions. In a molecular dynamics simulation 
containing explicit solvent water molecules (e.g. TIP3P44) instead of an implicit description of 
the solvent,  is necessary to define the simulated space. In this work, this option was not 
applied, but like the force field parameterization, boundary conditions are also very important 
in the molecular dynamics simulations field. 
 As mentioned beforehand, the size of a molecular structure, for instance, a protein, 
compared to the intracellular space is substantially small, considering that there is infinite 
space surrounding a protein in a biological environment. Being computationally impossible to 
simulate an infinite space, a set of cut-off distances defining the borders of the system must 
be applied. Here, a box containing the structure and the solvent molecules must be defined. 
The edges of the simulation box are described as the edges of the copies of simulation box. 
These copies placed around the simulation box are in contact with each other in a way that, 
for instance, a solvent molecule describing a trajectory that goes out of the bottom of the 
simulation box, will appear on the top of this same box.    
The size of the simulation box must be defined carefully in order to avoid self-interaction 
(the interaction between a molecule located in a boundary limit and itself). As mentioned in 
the E!"! section, a set of cut-off distances must be used, and a special method to deal with 
these interactions is through the application of the Particle Mesh Ewald (PME)45.  
2.1.4. Predicting the Association Energy 
One of the most important values to be determined in this kind of simulation is the Gibbs 
free energy of association. The importance of these values is revealed in several 
computational studies, such as the evaluation of the binding of a protein with small ligands 
(e.g. enzyme-ligand binding), or the binding between larger structures like two proteins 46-49. 
It is in the former subject that this free energy prediction took relevant weight in this work. 
Here, the method used to calculated the Gibbs free energy (!! ) was the Molecular 
Mechanics/Poisson-Boltzmann Surface Area (MMPBSA)50 implemented in the molecular 
simulation package AMBER30. More accurate methods could be used for the same purposes, 
such as the Free-Energy Perturbation(FEP) and the Thermodynamics Integration(TI) 
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methods, which in fact return better results. The reason for the choice of the MMPBSA 
method in detriment of FEP and TI is the higher computational efficiency of the MMPBSA. 
For protein-protein association analyses, MMPBSA presents relatively good agreement to 
the experimental results without compromising the computational time required. Only the 
MMPBSA method will be described in the following section because it was the only free 
energy calculation method used in this work. 
2.1.4.1. Molecular Dynamics/Poisson-Boltzmann Surface Area 
The values of free energies calculated through molecular mechanics methods are not 
accurate enough to perform, for instance, a comparison between different systems. This 
feature relies in intrinsic properties of the MM method where the zero point of the energies 
descriptors must be parameterized, which in most cases is not the same for all force fields 
and the approximations necessary to solve the equations mentioned beforehand also induce 
a certain level of errors. This error accumulation leads to significant differences in the final 
value, making it devoid of scientific meaning. Instead of considering only one final free 
energy value, the binding free energy values can be compared based on error cancelation, 
retrieving a variation on the binding free energy, which is provided of scientific accuracy. In 
this work, these values are used for the analysis of the variation of the binding free energy of 
the system when a residue on a protein-protein surface is mutated by an alanine. The 
resulting Alanine Scanning Mutagenesis Method is described in the results section. 
The MMPBSA methodology conjugates a molecular mechanics energy calculation with a 
molecular dynamics simulation in implicit solvent. The binding free energy can be calculated 
using the thermodynamic cycle shown in Figure 5, in which ∆Ggas is the interaction free 
energy between the two binding partners in the gas phase, and ∆!!"#$!"#  , ∆!!"#$!"#"$!"#!∆!!"#$!!"#$%& !are the solvation free energies of the two binding partners and the 
complex, respectively.  
  
                     
 
 
Figure 5: Thermodynamic cycle used to calculate the binding free energy 
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The binding free energy of two molecules in a complex is defined as the difference 
between the free energy of the complex and the respective monomers (11). 
The free energy of the complex and the respective monomers can be calculated by 
summing the internal energy (bond stretching, angle bending, and torsional energy), Einternal; 
the electrostatic and the van der Waals interactions, Eelectrostatic and EvdW; the free energy of 
polar solvation, Gpolar solvation; the free energy of nonpolar solvation, Gnonpolar solvation; and the 
entropic TS contribution for the molecule’s free energy as is written in equation (12). 
The first three terms are retrieved from the force field applied in the molecular dynamics 
simulation. The electrostatic solvation free energy can be calculated by solving the 
Poisson−Boltzmann equation with the Delphi software51-53, which has been shown to 
constitute a good compromise between accuracy and computing time. During the Poisson-
Boltzmann equation solving process, two different dielectric constants are assigned in order 
to simulate two different environments: one refers to the external/solvent medium which is 
normally assigned with the value 80 (! = 80) for water solvent medium or ! = 1 in case of 
vacuum, and 2! < !! < 4 in the case of the solute/protein environment. 
The nonpolar contribution to solvation free energy by the van der Waals interactions 
between the solute and the solvent, and cavity formation, is modeled as a term dependent on 
the solvent-accessible surface area of the molecule. It is estimated using the empirical 
relation, 
where A is the solvent-accessible surface area calculated by the molsurf program, which is 
based on the idea primarily developed by Michael Connolly 54 and it is implemented in the 
AMBER molecular package. α and β are empirical constants, with values 0.005%42 kcal Å-
2 mol-1 and 0.92 kcal mol-1, respectively. The entropy term, obtained as the sum of the 
translational, rotational, and vibrational components, will not be calculated because it is 
assumed, on the basis of previous work, that its contribution to the ΔΔGbinding is negligible55,56. 
 
 
 
 
 ∆!!"#$"#%!!"#$%&#$ = !!"#$%&' − !(!"#$%&!!"#"$%&' ! (11)  
 
!!"#$%&#$ = !!"#$%"&' + !!"!#$%&'$($)# + !!"# + !!"#$%!!"#$%&'"( +!!"!#"$%&!!"#$%&'"( − !" ! (12)  
 ∆!!"!#"$%& = !" + !! (13)  
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2.1.5. Molecular Docking 
Molecular Docking is one of the most used molecular modeling methods in computer-
aided drug design. This method is usually the first approach in the drug discovery process 
when the receptor structure is known, often extracted from the Protein Data Bank (PDB) 
11,12or similar database. Instead of just characterizing the position and orientation of one 
ligand inside the receptor binding site (docking campaign), this method reflects its full 
benefits in the characterization and sorting of several ligands (virtual screening).  The main 
goal of virtual screening campaigns is to select the compounds that have higher probabilities 
to develop a strong binding (e.g. inhibitor or substrate) and ranking them by their docking 
score and/or predicted binding energy.  
Molecular docking software are characterized by their search algorithm, sometimes 
named optimization algorithm, and their scoring function. The differences in the search 
algorithms are related to the model and the allowed degrees of freedom in the ligand and 
receptor structures. Looking at the scoring functions, some software adopts molecular 
mechanics model approximations like in the force field energy calculation, or empirical or 
knowledge-based scoring functions. The combination and tuning of the search algorithm and 
scoring function is always dependent of the accuracy/computational demand relationship that 
dictates the general usage of the program, especially in databases containing a vast number 
of compounds.  
There are good reviews in the literature concerning molecular docking, e.g. the reviews 
from Sousa et. al 18,57. 
2.1.5.1. Search Algorithm 
The simplest search algorithm to be considered is an algorithm that treats all the complex 
units as rigid bodies and only the rotation and translation of the units around each other are 
considered. This type of algorithms can be very useful in virtual screening campaigns, in 
which a large amount of ligands are evaluated. The speed of this kind of methods allows the 
analyses of large databases of small ligands, and suits even better in the docking of large 
structures as is the case of protein-protein docking58. On the other hand, the molecular 
description is not enough in the cases where some conformational changes have to take 
place in order to allow a proper interaction between the ligand and the receptor59. In these 
cases some flexibility (or even the full flexibility) of the complex is required and is 
implemented in the search algorithms of the docking software through three different 
methods: systematic, random or stochastic and simulations methods. 
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In the systematic methods category, the conformational search, fragment-based and 
database-based algorithms are included. The conformational search algorithm is based on 
the analysis of all possible conformations originated by the rotation of the dihedral angles of 
the ligand. In case of the fragment-based, the algorithm tries to bind small parts of the ligand, 
adding groups to the initial structure until the full structure is completely docked in the 
receptor binding site. Regarding the database-based method, this algorithm is based on the 
docking of rigid structures. The ligand structures are generated computationally or 
experimentally and only the structures that present higher probability to exist are considered. 
Random or stochastic methods are the most applied search algorithms in docking 
software. An example of a random algorithm is the Genetic Algorithm (GA) implemented in 
AutoDock or Gold60,61, where the search routine is based in the Darwin survival theory and 
the Mendel genetics processes like mutations and genes transmission. Another algorithm 
often implemented in docking programs is the Monte Carlo algorithm, which is very useful 
when it is intended to evaluate a wide range of conformations, such as the Tabu algorithm. In 
this algorithm several structures are generated avoiding the creation of equal structures, 
giving also a wide variety of structures. 
The simulation search methods apply molecular dynamics simulations and/or energy 
minimization calculations. These methods are suitable for the optimization of the structures 
resulted from a previous virtual screening or docking campaign. The convergence rate of 
these algorithms is low and very computational demanding. 
 Published works like MADAMM (multi staged docking with an automated molecular 
modeling protocol), from Cerqueira et al.38, apply a combination of systematic algorithms and 
simulation methods, with a rigid body docking in order to improve the docking results. The 
major drawback of these protocols is the time required to evaluate all the conformations and 
the molecular simulations, which despite of improvements, are still considerably slow for a 
general application in a large database.  
2.1.5.2. Scoring Function  
Searching for the best conformation of a ligand-receptor binding complex could not be 
complete if the evaluation of these conformations took place. Actually, the evaluation 
(scoring) and the search routines are intercalated in the docking process. For instance, in the 
Genetic Algorithm, the elements of the genes can only be transmitted to the next generations 
if they are fit to survive.  
 As with the search algorithms, different software apply different methods to evaluate the 
binding of the ligand into the receptor binding site, namely: force field, empirical, knowledge-
based, and consensus scoring functions. The force field scoring functions are based on the 
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numerical calculation of the energy applied in the molecular energy descriptors described in 
the 2.1.2 section, just like internal energy calculation (bond stretching, angle bending and 
torsional energy). As mentioned beforehand, as the molecular descriptor becomes more 
sophisticated, the computational demand becomes an issue, turning the application of this 
kind of scoring functions not practical for fast docking processes. 
The empirical scoring functions are based on experimental observations, in which it is 
intended to recreate these values by approximated and parameterized functions. Despite the 
speed of calculation of these functions, these parameters are not transferable to all 
structures, demanding constant parameterization, function tuning and constant search for 
experimental values (which are not availability for all cases). Knowledge-based functions 
employ the same parameters approximation, but instead of an energy calculation, these 
functions are focused on geometry optimization.  
Instead of being a different method to score docked conformations, the consensus 
functions are the combination of the previously mentioned scoring functions. This approach 
is based on error cancelation while maintaining the advantages of the features of each 
method.  
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3. Results and Discussion  
This chapter intends to report the accomplished work, either published or to be published, 
describing the resultant software. The descriptions of the new bioinformatics tools are based 
on the correspondent scientific papers, complemented with relevant information regarding, 
the software used to perform molecular calculations, theoretical information or developments 
carried out since their release. The visual inspection of the structures and the results is 
obtained by the inclusion of all developed tools in the world wide web molecular visualizer, 
Visual Molecular Dynamics (VMD).  
The first section of this chapter describes the software vsLab, which was developed to assist 
the user in virtual screening campaigns and is based on one of the most used molecular 
docking software, AutoDock. This program allows the user to perform a virtual screening 
campaign in a very easy-to-use fashion. All the parameters required to carry a molecular 
docking prediction are set in a Graphical User Interface (GUI) in which the resultant ranking 
of the docked ligands is displayed, sorted by the docking score returned by the AutoDock 
software. The code under the GUI manages all the files necessary to launch the AutoDock 
calculations and also deals with all intermediate steps of the molecular docking protocol, 
including the structure files preparation and the generation of the affinity atoms grid maps 
required by the AutoDock software.   
The second part of this chapter focus on the description of the Chem-Path-Tracker (CPT) 
software. This tool aims to find and highlight chemical motifs present in structures. These 
motifs can be formed by different type of structures and purposes, such as the coordination 
of a metal-enzyme binding site, the alignment of different residues in order to form a cation-π 
interactions chain, or the hydrogen bonds formed inside a water tunnel. The algorithm 
implemented in the CPT software is a modified version of the Dijkstra’s algorithm, which 
main goal is to find the closest path between two points containing several nodes between 
them. Defining the nodes as atoms or residues of different types is possible to trace different 
paths between the nodes to form cluster/motifs of nodes. In this way is possible to highlight 
structural motifs and thus reveal the surrounding environment.  
The third section of this result and discussion chapter stands for the description and 
validation of the molecular structure analyzer VolArea. This software calculates and analyzes 
different structural features like the surface area accessible to different compounds such as 
the solvent, calculating in this way the solvent accessible surface area (SASA). VolArea is 
also constituted by an algorithm to calculate volume, both atoms and empty spaces volume 
such as cavities and clefts. This program has proven itself to be very useful in molecular 
dynamics simulations analysis, as it was possible to highlight and quantify events observed 
in the visual analyses, such as the closure of the binding site. It was also possible to analyse 
   FCUP 
COMPUTER-AIDED DRUG DESIGN - Lead Discovery 
42 
 
contacting surfaces, such as protein-protein interacting surfaces. The volume algorithm was 
later improved and adapted to the usage of the Graphical Processing Units (GPU), providing 
this tool with a high parallelized algorithm, originating a huge gain in computing time.   
The forth and final section of this chapter is devoted to the Computational Alanine 
Scanning Mutagenesis (CompASM) tool. This software was developed in order to bring the 
alanine scanning mutagenesis (ASM) method to the general usage, allowing the usage of 
this methodology by non-expert users. The ASM method, either experimental or 
computational, maps the importance of residues in a protein:protein interface surface. The 
method is based on the variation in the binding free energy of a complex triggered by the 
mutation of a residue by an alanine residue. The computational variant of this method has 
shown good balance between computational time and accuracy, when compared with more 
accurate technics such as Thermodynamic Integration (TI) or Free-Energy Perturbation(FEP) 
calculations. The CompASM protocol uses a molecular trajectory performed in the AMBER 
molecular simulation package in implicit solvent, using the Generalized Born solvation 
method, and the calculation of the binding energy applying the Molecular 
Mechanics/Poisson-Boltzmann Surface Area (MMPBSA) method, also implemented in 
AMBER. 
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3.1. Virtual Screening Lab (vsLab) 
 
Molecular docking is nowadays an important tool in the search for promising compounds 
as drug candidates, having become a daily used tool in the drug discovery process. Despite 
the relative success of some docking software in the prediction of ligand-receptor binding 
conformations, the complexity of these programs are often high, requiring a slow learning 
process, which leads to difficulties in the usage of these software by non-expert users. This 
is an obstacle and a cornerstone issue for the research teams in the fields of Chemistry and 
Biochemistry, whom are interested in conducting this kind of calculations but do not have 
enough programming skills. To overcome these limitations, we have designed vsLab (virtual 
screening Lab), an easy-to-use graphical interface for one of the most used molecular 
docking softwares AutoGrid/AutoDock; vsLab has been included into VMD as a plug-in. This 
program allows almost anyone to use AutoDock and AutoGrid for simple docking or for 
virtual screening campaigns without requiring any deep knowledge about these techniques. 
The potential associated to this plug-in makes it an attractive choice not only for educational 
purposes, but also for more advanced users whom are able to use vsLab to increase 
workflow and productivity of everyday tasks.
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Article I 
 
“VsLab - An implementation for virtual high-throughput screening using 
AutoDock and VMD“ 
 
Adapted from: 
Cerqueira N.M.F.S.A., Ribeiro J., Fernandes P.A, Ramos M. J. 
Int J Quantum Chem 111: 1208–1212, 2011. 
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3.1.1. VsLab - An implementation for virtual high-throughput 
screening using AutoDock and VMD 
N.M.F.S.A. Cerqueira, J. Ribeiro, P.A Fernandes, M. J. Ramos 
REQUIMTE , Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do 
Porto, Rua Campo Alegre s/n , 4169-007 Porto, Portugal. 
 
3.1.1.1. Abstract 
 
Molecular docking is a key tool in structural molecular biology and computer-assisted drug 
design. The goal of ligand-protein docking is to predict the predominant binding mode(s) of a 
ligand with a protein of known three-dimensional structure. There is much docking software 
that has been successfully used in a myriad of keystone problems, however, as commonly 
happens with most of the scientific software, the programs are often complex and a deep 
knowledge is required for the common user to carry out standard steps. This is an obstacle 
and a cornerstone issue for the research teams in the fields of Chemistry and the Life 
Sciences, who are interested in conducting this kind of calculations but do not have enough 
programming skills. To overcome these limitations, we have designed vsLab (virtual 
screening lab), an easy-to-use graphical interface for the well-known molecular docking 
software AutoGrid/AutoDock that has been included into VMD as a plug-in. This program 
allows almost anyone to use AutoDock and AutoGrid for simple docking or for virtual 
screening campaigns without requiring any deep knowledge about these techniques. The 
potential associated to this software makes it an attractive choice for more advanced users 
that can use vsLab to increase workflow and productivity of everyday tasks. The program 
can be freely obtained at http://www.fc.up.pt/pessoas/nscerque/vsLab/vLab/HomePage.html 
 
Keywords: Molecular Docking, Virtual Screening, vsLab, software, AutoDock. 
3.1.1.2. Introduction 
In the field of drug discovery, molecular docking software is playing a relevant role, as 
identifying molecules that might fulfill the stringent criteria necessary to become a drug has 
often been compared to searching for a needle in a haystack. These methodologies seek to 
simulate the structure of protein/ligand complexes, in which the receptor is usually a protein 
or a protein oligomer and the ligand is either a small molecule or another protein. The 
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solutions are then sorted out using a scoring function, which allows estimating the 
conformation of the ligand that tends to interact more strongly with the studied receptor62. 
Initially, molecular docking was only used to predict and reproduce protein-ligand 
complexes, but the successes of these early studies led to the exploration of molecular 
docking as a promising tool in drug discovery in order to find hits and optimize lead 
compounds.  In the quest of predicting this type of interactions, several docking algorithms 
have been developed in the last two decades with commercial, freeware and open source 
licences 63-70. The efficiency and accuracy of these programs is well established in the 
literature, where a source of successful examples and software comparisons can be easily 
found 71,72. However, as commonly happens with much scientific software, the programs are 
complex to use and a deep knowledge is required for the common user to carry out standard 
procedures. In the particular case of molecular docking software, the learning step increases 
when the user intends to repeat the same task several times in order to screen thousands or 
millions of compounds.  
As these methods are becoming standard tools for everyday use, in a wide range of 
experimental sciences in the fields of Chemistry and the Life Sciences, there is a constant 
challenge to turn these struggling programs more user-friendly and with more accessible 
front-ends to allow their use by non-expert users. In the literature, there are many graphical 
user interfaces (GUI) that help the user to prepare the input files and the execution of 
common tasks in these types of software.  However, the number of them that are free, user 
friendly and allow preparing virtual screening campaigns with a suitable graphical backend to 
analyse the results is very limited. Taking this into account we developed a plug-in for the 
VMD (Visual Molecular Dynamics) program73, called vsLab, which allows any user to dock 
one or several ligands into the binding pocket of a protein in one step fashion, without the 
frustrating preparation of several input files and the execution of multi sequential and 
complex steps. 
The main idea behind vsLab is therefore to turn molecular docking as easy as it can get, 
allowing its use in everyday work situations in a couple of clicks, without disregarding the 
reliability and reproducibility of the results.  To ensure this key asset, vsLab uses in its core 
system, one of the most popular molecular docking software, i.e., AutoDock74.  The 
developed GUI has several modules that ensure a smooth execution of the program, 
requiring only minimal user intervention to start a simple docking job or more complex high-
throughput virtual screening campaigns. 
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3.1.1.3. AutoDock  
VsLab allows to predict the docking of a single ligand to the binding pocket of a protein, or 
simulate virtual screening campaigns searching for hit or lead compounds from a large 
compound database. In order to improve the attractiveness and utility of the program, it has 
been encapsulated into the VMD program 73, and uses AutoDock 75 74 to perform molecular 
docking simulations to ensure the reliability and confidence of the results. 
We have chosen AutoDock because it is one of the most popular molecular docking 
software available in the market and is freely available to download, under the GPL license, 
by any user 57. This software can efficiently predict, with an elevated degree of confidence, 
the correct binding pose of several ligands in a wide range of receptors 76 68 77-80. This 
program is now in version 4.2 and with the AutoDockTools facilities allows the application of 
this technique to a very large range of biological systems. The search algorithms available in 
AutoDock are the Genetic Algorithm (GA), the Local Search (LS) algorithm and the GA/LS 
hybrid algorithm named Lamarckian Genetic Algorithm (LGA). This last algorithm was 
introduced in the third version, being the most promising search algorithm offered by this 
program. The Genetic algorithm implements genetic notions, applying them to the data in 
study. For instances, in case of molecular structures, the 3D coordinates of the atoms are the 
phenotype and all information regarding the angle rotation angles, torsions etc. is printed in 
the genotype. The gains of the Lamarckian algorithm against the GA and LS algorithms is in 
the local minimum search between generations, and the inclusion of this information in the 
descendants and the efficiency in the convergence obtained by this inclusion. This feature is 
the key character of the Lamarckian theory assuming the transmission of the phenotype 
characteristics to the next generations. The scoring function implemented in the AutoDock is 
a semi-empirical force-field based scoring function, where the internal, torsional and 
electrostatic energies are evaluated applying the parameterization already implemented in 
the software. Different parameters are also allowed by the inclusion of a parameterization 
file, which like in most cases, is not advised due to the introduction of a new source of error.  
In spite AutoDock usage advantages, the use and handling of AutoDock is not 
straightforward for non-expert users, since it requires several separate pre-docking steps, 
e.g., ligand preparation, receptor preparation, and grid map calculations, before the actual 
docking process can take place. Existing tools, such as AutoDockTools (ADT) 74 and BDT 
(Automatic protein-ligand docking for everyone) 81, integrate individual AutoDock steps within 
a graphical user interface, and provide automated features for simple docking runs. Still, 
neither its use is trivial nor it contains the capability to effectively process and analyze 
millions of compounds in a single execution. The former issue can be overcome using a set 
of UNIX scripts, but its execution is rather difficult and complex, which turns its use almost 
impossible for non-expert UNIX users. 
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3.1.1.4. Graphical User Interface 
vsLab intends to solve most of difficulties encountered in the docking process and 
considerably reduces the learning step required to start using this type of software, avoiding 
the creation of the several input files and complex high-level automated scripts to execute 
the program. To accomplish this objective, the program includes a set of graphical user 
interfaces that turns molecular docking process as easy as a couple of clicks.  
vsLab is installed as a VMD plug-in and only few dependencies, concerning the 
localization of AutoDock and AutoGrid executable files and AutoDockTools path, have to be 
set up. Once installed the program can be found in the extension menu of VMD, under the 
sub-menu called Modelling. 
When the program is launched the main interface is composed by a set of menus that can 
be used to prepare a new run, open previous executed files, and start new calculations, 
among other options. In the same interface we can also find two tabs that are used to display 
and sort out the results of single or multiple docking jobs, as well as review the parameters 
used to run those calculations (Figure 6A). 
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Figure 6: Graphical user interfaces available in vsLab. A: Main interface. B: Input file interface. C: AutoDock 
options interface. D: AutoGrid options interface. E: Visualizing the results using VMD front-end. 
To create a simple docking or a virtual screening campaign job, the user just has to select 
the receptor and the ligand, or group of ligands, which are going to be screened during the 
docking procedure (Figure 6B). The receptor must be previously uploaded to the VMD 
interface and selected on the interface. The ligands can have the pdb or the mol2 file format 
and they can be independently uploaded into the interface, one at a time or simultaneously 
through the selection of the directory where they can be found. The latter option is useful 
when the user wants to dock several thousands or millions of compounds into the same 
receptor and undergo virtual screening campaigns. 
The same window also allows the user to set up the AutoGrid and AutoDock parameters 
that are required to run the docking simulation. The AutoDock Tab allows the user to change 
a set of parameters that control the execution of the AutoDock program. For instance, it 
allows to adjust the type of algorithm that will be used during the docking process, and set up 
the parameters that control its execution  (Figure 6C). All entries in this interface are pre filled 
with standard values, but the user can modify them for his/her needs, namely, the number of 
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solutions that will be generated in each run, the number of evaluations, as well as the 
number of generations and the population size that control the termination of the genetic 
algorithm. 
The AutoGrid tab includes all parameters that are necessary to run the AutoGrid 
executable. This program maps the binding site of the target protein, and calculates the 
atomic affinity potentials for each atom type in the macromolecule, such as aliphatic carbons, 
aromatic carbons, hydrogen bonding, oxygens, etc. To select such region vsLab offers a set 
of buttons that allows the user to draw, resize and move a box around the protein easily 
(Figure 6D). The region inside of that box is the one that will be analyzed by the AutoGrid 
executable, and should therefore include all atoms/residues of the receptor that the ligands 
should interact with (in this part it is advisable that the user uses the selection tools of VMD 
to highlight the active site). The height, width and depth units of the square box present in the 
interface are in angstrom, but these values are normally converted to a number of grid points 
in AutoGrid, i.e., the number of points that will be used within the grid map (in each axis) to 
calculate the potential energy of a specific ` probe ' atom or functional group over a 3D space 
around the receptor surface. The number of grid points in each axis depends therefore on 
the size of the square and on the space that is used to distance each point on the grid (which 
can also be easily changed in the vsLab interface, in the grid spacing entry).  
Since sometimes it is not clear to evaluate which area of the receptor is being analyzed, 
the interface offers one option that calculates the ligand accessible surface area for that 
selection. The resolution of the surface can be modified and the color changed by the type of 
amino acids, exposed area, etc, which can help the user to choose or examine the binding 
region with more precision. 
 
  
Figure 7: Sample VMD sessions displaying the results obtained from the vsLab plug-in. 
Once these variables have been set up and saved, the user can submit the input file for 
calculation. The process can take several minutes or several days depending on the number 
of ligands that are analyzed and the variables imposed to the system. During the execution 
of the input file, vsLab stores all data in a database that can be subsequently uploaded in the 
same interface and analysed using the powerful graphical front-end of VMD (Figure 7). The 
interface allows the user to sort out the results taking into account the score attributed by 
AutoDock to each docked ligand/solution, or by the calculated KI (Inhibition constant) that 
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estimates the inhibitory strength of that ligand for the analyzed protein. These values can 
then be used to select the best binding pose of a putative ligand inside the active site of the 
receptor (if only one ligand was analyzed), or search for possible hit or lead compounds, if 
more than one ligand has been investigated. 
VsLab can also be used when the location of the binding site is unknown. This is 
commonly refereed to as “blind docking”, when all that is known is the structure of the ligand 
and the macromolecule. In such cases, the user has to set up the program to search for the 
entire surface of the protein (or other macromolecule) of interest. In those situations, it is 
advisable to divide the macromolecule in different and adjacent sections in order to attain a 
good balance between the analyzed area and the resolution of the grid map, which should 
contain the maximum number of points in each dimension82. 
3.1.1.5. Conclusions 
vsLab removes most of the complexities and organizational problems associated with the 
use of molecular docking software. It provides a convenient and efficient solution to dock a 
ligand to a specific receptor as well as to implement more complex high-throughput virtual 
screening jobs. The docking session is fully integrated and automated and all inputs files are 
specified via a graphical user-friendly interface that allows any user to use it without requiring 
any previous knowledge on the molecular docking area. 
The inclusion of AutoDock in vsLab guarantees the reproducibility and reliability of the 
results and the VMD symbiosis allows the user to explore its powerful graphical front-end to 
analyze the final results. The simplicity of the software makes it also an attractive tool not 
only for education purposes, but also for more advanced users that can use vsLab to 
improve the workflow and production of everyday tasks. We believe that vsLab contributes 
significantly to the progress of the progress of the research teams in the fields of Chemistry 
and the Life Sciences. 
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3.2. Chem-Path-Tracker 
The internal organization of proteins is a crucial subject in the study of their structure. The 
function of an enzyme, for instance, is regulated and mediated by the action of several 
fragments (motifs) that together lead to the correct catalytic mechanism. However, the 
detection of these chemical motifs is rather difficult because they often consist of a set of 
amino acid residues separated by long, variable regions, and they only come together to 
form a functional group when the protein is folded into its three dimensional structure. In 
order to simplify the analysis of these chemical motifs and give access to a generalized tool 
for all users, we developed Chem-Path-Tracker. This software is a VMD plug-in that allows 
the user to highlight and reveal potential chemical motifs in a very easy and intuitive fashion. 
The analysis is based on atoms/residues pair distances applying a modified version of 
Dijkstra’s algorithm, and it makes possible to monitor the distances of a large pathway, even 
during a molecular dynamics simulation. 
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Article II 
 
“Chem-Path-Tracker: An automated tool to analyze chemical motifs in molecular 
structures “ 
 
Adapted from: 
Ribeiro J.,Cerqueira N.M.F.S.A., Fernandes P.A., Ramos M. J. 
2013 (submitted). 
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3.2.1. Chem-Path-Tracker - An automated tool to analyze chemical 
motifs in molecular structures. 
J. V. Ribeiro, N.M.F.S.A. Cerqueira, P.A. Fernandes, and M.J Ramos  
REQUIMTE , Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do 
Porto, Rua Campo Alegre s/n , 4169-007 Porto, Portugal. 
3.2.1.1. Abstract 
In this article we propose a method for locating functional relevant chemical motifs in 
protein structures. The chemical motifs can be a small group of residues or structure protein 
fragments with highly conserved properties that have important biological functions. 
However, the detection of chemical motifs is rather difficult because they often consist of a 
set of amino acid residues separated by long, variable regions, and they only come together 
to form a functional group when the protein is folded into its three dimensional structure. 
Furthermore, the assemblage of these residues is often dependent on non-covalent 
interactions among the constituent amino acids that are difficult to detect or visualize. To 
simplify the analysis of these chemical motifs and give access to a generalized use for all 
users, we developed Chem-Path-Tracker. This software is a VMD plug-in that allows the 
user to highlight and reveal potential chemical motifs requiring only a few selections. The 
analysis is based on atoms/residues pair distances applying a modified version of Dijkstra’s 
algorithm, and it makes possible to monitor the distances of a large pathway, even during a 
molecular dynamics simulation. This tool turned out to be very useful, fast and user-friendly 
in the performed tests. The Chem-Path-Tracker package is distributed as an independent 
platform, and can be found at 
http://www2.fc.up.pt/PortoBioComp/database/doku.php?id=chem-path-tracker. 
 
Keywords: Protein networks, Dijkstra’s algorithm, motifs, VMD 
3.2.1.2. Introduction 
The development of new and effective drugs is strongly dependent on the 
identification of new drug targets with reduced side effects and better efficiency. 
Resolving this issue depends partially on a thorough understanding of the biological 
function of proteins. Unfortunately, the experimental determination of protein function, 
when possible, is expensive and time consuming. To support and accelerate this 
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endeavor, one of the major challenges in bioinformatics is to develop robust methods 
capable of interpreting and extracting important data concerning molecular structures 
that enclose specific and conserved features, such as chemical motifs, from which 
the chemical/biological function depends on. 
Generally speaking, chemical motifs are just like electronic circuits that are built 
from simple boolean gates and are required to perform specific functions. In a 
chemical environment, chemical motifs can be a small set of residues or structure 
protein fragments with highly conserved properties that perform some important 
biological function. For instance, these conserved motifs may be a cluster of amino 
acid residues that are required to maintain a metal ion bound to a specific region of a 
protein or even to allow protein-protein interactions. They can also be a large group 
of residues involved in long range proton/electron transfers or even determinant to 
the three dimensional structure of the protein83.  
The detection of chemical motifs is however rather difficult because they often 
consist of single conserved amino acid residues separated by long, variable regions, 
and they only come together to form a functional group when the protein is folded into 
its three dimensional structure. Furthermore, the assemblage of these residues is 
often dependent on non-covalent interactions among the constituent amino acids that 
are difficult to detect or visualize. Additionally, it is becoming increasingly clear that 
the interactions between amino acids at the global level are the deterministic factor of 
the chemical motifs, and an investigation involving pairwise interactions alone is not 
sufficient to understand the basis of the uniqueness of these chemical motifs84. 
Chemical motifs are generally found deeply buried in the protein structure. This 
allows them to maintain their proper spatial configuration that is fundamental for their 
specific function and to be protected from the solvent or other molecules that might 
interfere with their function. In this regard, many authors suggest that chemical motifs 
can be seen as independent regions in the protein structure that are surrounded by 
shielding residues that protect their chemical identity and at the same time ensure 
their correct location and orientation85.   
Based on these assumptions we developed a new bioinformatics tool, called 
Chem-Path-Tracker, for locating functionally relevant motifs in protein structures by 
means of protein structured networks. These networks are constructed at a coarse-
grain level, considering atoms or resides as node points and are generated based on 
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a starting point that is pre-selected by the user and a cut-off distance that will 
determine the maximum distance between two consecutive nodes.  The final results 
will generate several pathways (networks) that interconnect the nodes that fulfill the 
requirement of the selected conditions. For instance, if these requirements are set to 
search for specific interactions, such as hydrogen bonds, then all the possible 
hydrogen bonds between the selected nodes will be visualized. 
Chem-Path-Tracker includes a graphical interface that has been embedded in 
VMD and allows an easy and simple preparation of the input files as well as the 
analysis of the output files. The software works with any structure that can be 
identified by the VMD software. This means that it can analyze a wide range of static 
structures such as a PDB file retrieved from the protein databank or even multi-frame 
structures such as molecular dynamics (MD) simulations performed with different MD 
software (amber, namd, gromacs, etc). In the latter case, the software provides a 
statistical treatment of the values and sorts the best pathways based on the data that 
was collected.  The software can be found at: 
http://www2.fc.up.pt/PortoBioComp/database/doku.php?id=chem-path-tracker. 
In the next sections it is described the algorithm, the graphical interface, as well as 
several examples that demonstrate the potential of Chem-Path-Tracker. 
3.2.1.3. Software Description 
3.2.1.3.1. Graphical Interface 
Chem-Path-Tracker was developed in Tcl/Tk and was included in VMD as a plug-
in. This allows the program to explore all the powerful graphical backend of VMD as 
well as all the facilities provided by this software, such as reading several file formats 
including several types of multi-frame structures like the ones generated by molecular 
dynamics. The program can be directly integrated in the extensions/analysis menu of 
VMD from where it opens as a graphical user interface (GUI) (Figure 8). 
Once the input files are set up, all calculations are performed by VMD, without the 
use of external programs. Therefore, our plug-in just requires a structure or a 
trajectory file to be loaded into VMD. Furthermore, all calculations that are produced 
by Chem-Path-Tracker can be analyzed by the plug-in itself or can be written in an 
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appropriate txt file format, which allows the exchange of data with other applications, 
such as spreadsheets. 
 
 
 
Figure 8: Chem-Path-Tracker’s Graphical User Interface (GUI) input tab. In this tab the user can set the parameters and 
the selection to be applied in the pathways’ search..  
3.2.1.3.2. A modified Dijkstra’s algorithm 
The main algorithm behind Chem-Path-Tracker is the Dijkstra’s algorithm 8,9. This 
algorithm starts at a pre-determined point (here called the starting point) and tries to 
connect all the other points  (here called nodes) in such a way that each point is 
visited just one time. The distance between all the node points is then evaluated in 
such a way that the shortest path between two consecutive points is always chosen.  
The algorithm requires therefore the selection of a starting point and a set of nodes 
that the user wants to link to the starting point.   
In Chem-Path-Tracker, the starting point of Dijkstra’s algorithm can consist of any 
point of the three-dimensional space of the biological system under study, available 
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on the VMD graphical interface, which the user can choose using the selection tools 
available. E.g. the VMD command “index 100” will select the point in space that is 
occupied by the atom with that index. When more than one atom is selected, the 
program always calculates the geometric center of that selection and uses it as the 
starting point. For example, if the user selects residue 120 as a starting point, the 
program will take into account the position of the atoms that are part of residue 120, 
and will calculate their geometric center. This point will then be used as the starting 
point.  When the starting point is selected it will be displayed in the graphical 
interface as a yellow sphere. 
The nodes can be defined in Chem-Path-Tracker using the same protocol that was 
described before. These points should identify key features in the structure of the 
object that the user wants to analyze and link them with the starting point. E.g. if the 
user wants to search for all possible hydrogen bonds in a protein structure, then he 
needs to select the atom types that are good electron donors and those that are good 
proton donors. However, this type of selection can become time consuming and 
therefore less efficient. In order to overcome this issue, we added two options for the 
selection process:  PT (points) and AVG (average). When the user selects the PT 
option, the atoms included in the selection will be treated as individual points in the 
search algorithm. This option is very useful if the user wants to select a certain atom 
type. For instance in the example given above, if the user wants to select all atoms 
that are electron donors, he/she could activate option PT and select all the atoms of 
the protein whose atom type possesses the relevant characteristics.  
When the AVG option is used, the software will calculate the geometric center of 
each residue present in the selection, and only those points will be included in the 
algorithm. For instance, if the user selects the AVG option and the atom selection 
includes all tyrosine residues present in the protein, only the geometric center of all 
tyrosine residues in the protein will be included in the algorithm. However, in this 
example, if the user chooses to select the PT option instead, all atoms of the tyrosine 
residues available in the protein will be explicitly included in the algorithm. 
Once the starting point and the nodes are defined, the software is ready to run. In 
Chem-Path-Tracker, we have changed the original Dijkstra’s algorithm in order to 
make it more useful in a molecular framework (Figure 9). The software will initiate at 
the starting point and will begin the search for the closest “node point”. There is a cut-
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off value that limits the distance that is used to search for new node points from the 
starting point. This means that this variable should be used to control the maximum 
distance that separates two consecutive nodes, which can be correlated with the type 
of interaction that we are seeking. E.g. if the user is searching for hydrogen bonds in 
a protein structure, the cut-off can be defined as 3Å between heavy atoms. This will 
ensure that the distance between each node in the final pathway will be always below 
3Å. The many nodes that do not fulfill such requirement are discarded and the final 
pathway will not include them.  However, in some cases, more than one node will 
fulfill the requirement imposed by the cut-off distance. Here, the nodes with the 
closest distance from the starting point will be chosen and the process will be 
repeated until all possible nodes are linked to each other. This will create the main 
pathway. All points that fulfill the cut-off distance in relation to the same starting point, 
are used to create ramifications of the main pathway. This will lead to the formation of 
secondary pathways that connect a starting point to different nodes. When a 
ramification occurs, the software ensures that the new pathways are unique and do 
not share any of the nodes from other pathways, except those that are common until 
the ramification starts. The number of pathways and their end points are dependent 
on the cut-off distance that is chosen. The original Dijkstra’s algorithm can be 
activated when the cut-off distance is increased to infinity. 
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Figure 9:!General algorithm implemented in Chem-Path-Tracker software. 
 
3.2.1.3.3. The output of Chem-Path-Tracker 
Once the calculation is complete, Chem-Path-Tracker stores all the results in a 
text file with a bpf extension. This file stores all the information generated in the form 
of a table, and each line of this table contains the pair of nodes that are part of the 
pathways generated. If the system that is studied is a protein, each node will be 
presented in this table by the residue name and the respective identification. This 
table will provide also the score of each pair of nodes given by the scoring function. 
In the case of multi-frame structures, such as the trajectories provided by molecular 
dynamics simulations, Chem-Path-Tracker will provide additionally a statistical 
overview of the score of each pair of nodes during the selected frames, i.e. the 
average value and the standard deviation.  
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Figure 10: Chem-Path-Tracker’s Graphical User Interface (GUI) output tab. This tab presents the final results of the 
PCET pathways’ search. 
In order to turn the analysis of the results more clear, all this information can be 
easily controlled in the output tab of Chem-Path-Tracker.  Here, each pair of nodes is 
represented as balls and the connection between them as sticks. The color of the 
nodes is the same of that in the selection done for the input, in order to facilitate their 
identification. The color of the lines linking two nodes can be chosen by the user. If a 
multi-frame structure is selected, the color of the path is a function of their percentage 
of occurrence, in a scale from blue to red as the percentage rises from 0 to 100 %. 
As it was outlined before, Chem-Path-Tracker can generate more than one 
pathway starting from the initially selected starting point. Some times it is useful to 
analyze the shortest scored pathway that connects two nodes. Taking this into 
account we have implemented such facility in the output table of Chem-Path-Tracker 
in order to carry out such type of analysis. Here, the user just has to select two points 
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that are present on all the paths that were analyzed by Chem-Path-Tracker. Once 
this is complete, the programs will automatically give the best-scored pathway that 
links the two points based on the information collected previously.  If the user wants 
to analyze more than one pathway, he can color each pathway with different colors, 
facilitating thus each selection (see Figure 10). 
3.2.1.4. Software Validation 
In order to evaluate the applicability of the Chem-Path-Tracker software, we 
looked for special chemical motifs in several protein structures that are difficult to 
analyze even by experienced users. For this purpose we selected five protein 
structures: guanine deaminase, oxidosqualene cyclase, human growth 
hormone/receptor complex, aquaporin, and ribonucleotide reductase. 
Proteins guanine deaminase and oxidosqualene cyclase were used to 
demonstrate the capability of Chem-Path-Tracker to identify a network of residues 
around the active site. In the human growth hormone/receptor complex we tried to 
locate an unusual chemical motif, which involves a cluster of 9 residues that interact 
via cation-π interactions.  The aquaporin structure was used to identify the residues 
that interact more closely with a tunnel of water molecules located inside the protein 
structure and that have an important biological role. The enzyme ribonucleotide 
reductase (RNR) was used to demonstrate the capabilities of Chem-Path-Tracker to 
pursue residues that are involved in proton or/and electron transfer across the protein 
structure. In this case Chem-Path-Tracker was used in a multi-framed structure 
involving 20 ns of a molecular dynamics simulation. 
3.2.1.4.1. Chemical motifs surrounding active sites 
Some of the most interesting chemical motifs that have been conserved 
throughout the evolution of proteins are the active sites. These regions determine the 
function of proteins and are generally found in clefts or pockets within the protein 
structure. Structurally, an active site is lined up by a set of amino acid residues that 
participate directly or indirectly in a chemical reaction.  These residues are 
specifically aligned and oriented in the protein structure and are modeled by a set of 
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molecular interactions that turn that site unique both from structural and chemical 
points of view. 
Generally, only a small set of residues of the active site is analyzed either because 
those are the ones that are directly involved in the catalytic process or because they 
have somehow been shown to be important for the reaction. The surrounding 
residues are most of the time disregarded, although several studies have shown that 
these residues are equally important for the function of the enzyme, as they maintain 
the reactive residues close to each other and they can also change the chemistry of 
neighbor residues86-91. 
In this sense, Chem-Path-Tracker can be an extremely good tool to explore the 
networks of molecular interactions in the active site region, and highlight the 
neighboring residues that might interact with it through medium and long-range 
interactions. 
To exemplify the potential associated with Chem-Path-Tracker we have analyzed 
the active sites of 2 enzymes: guanine deaminase and oxidosqualene cyclase. 
3.2.1.4.2. Guanine deaminase 
The enzymes containing metal ions in their active sites are very interesting to 
analyze in this regard, because the protein scaffold has to maintain the ion bound to 
the protein structure and simultaneously assist the substrate binding and the catalytic 
process. This often leads to the formation of specific chemical motifs that are unique 
and determinant for the protein function92. The enzyme guanine deaminase is one of 
these cases with a zinc ion surrounded by a cluster of histidine residues in its active 
site93. The X-ray structure with the bound product (pdb code: 2UZ9) also reveals that 
the metal ion interacts very closely with the substrate and therefore it participates 
directly in the catalytic process.  
In order to exemplify some of the capabilities of Chem-Path-Tracker we have 
explored the structure of the active site of this enzyme. To achieve this, we started by 
selecting the zinc ion as the starting point (index 3546). The node points were 
generated based on one of the preconfigured option in Chem-Path-Tracker GUI, i.e. 
node points for hydrogen bonds (HBonds) and the substrate (resname XAN). The 
chosen cut-off distance of the search algorithm was set to 5.0 Å. 
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Figure 11:  Chemical interaction between the residues of the active site of the enzyme guanine deaminase that were 
highlighted by the Chem-Path-Tracker software. In pink are represented the amino acid residues that are located at the 
first coordination sphere of the zinc ion. 
 
The graphical representation generated by Chem-Path-Tracker reveals a network 
of interactions in which the zinc ion plays a central role.  The amino acid residues 
that interact more closely with the zinc ion involve an aspartate (Asp330) and a 
cluster of histidine residues (His82, His84, His240 and His279). These residues are 
located at the bottom region of the active site and are thought to be crucial for the 
stabilization of the metal in the protein structure as well as conferring a certain 
chemical reactivity. Chem-Path-Tracker was also capable of identifying several 
amino acid residues that do not interact directly with the zinc ion but stabilize the 
residues that are located in the first coordination shell. For example, Asp330 interacts 
directly with the zinc ion and its position is strongly stabilized by two short hydrogen 
bonds provided by neighbors Cys301 and Ser304. The same is also true for His84 
that is stabilized by Glu111 and the latter by Gln87, Tyr180 and Thr107. These 
results suggest that the structure and perhaps the chemistry of the active site of 
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guanine deaminase is supported by a network of interactions that are not confined to 
the residues that are locate in the first coordination sphere of the zinc ion. Some 
residues in this network of interactions can be found at 17 Å and 11 Å away from the 
zinc ion as it is the case of His146 and Cys281, respectively. These results suggest 
that these residues can also be equally important for the protein function together 
with some of the residues that are located in the first coordination shell of the zinc 
ion.  Of course that this requires further calculations and such analysis is out of the 
scope of Chem-Path-Tracker.  
3.2.1.4.3. Oxidosqualene cyclase  
Another interesting example involves oxidosqualene cyclase (OSC), an enzyme 
involved in the biosynthesis of cholesterol.  Cholesterol is a bulky lipid molecule, 
composed of four linked rings of carbon decorated with hydrogen atoms and a single 
oxygen atom. A collection of two dozen enzymes is needed to build cholesterol from 
simple starting compounds. Enzyme OSC performs the most complicated step in this 
process. It takes a long thin carbon chain, oxidosqualene, and folds it up, creating the 
four linked rings.  In order to explore the active site of this enzyme we analyzed the 
X-ray structure that contains the product of the reaction (PDB entry 1w6k)94.  
Since the reaction starts with the protonation of an epoxide, we selected the 
oxygen that is involved in that reaction, as a starting point (index 5909).  We then 
selected all the residues that can interact with the starting point by hydrogen bonds 
(automatic pre-selection HBonds). Since the active site is located near the protein 
surface and it is highly exposed to the solvent, we have also selected the water 
molecules that populate the active site and may be involved in the catalytic process. 
However, due to the high number of water molecules that surround the active site we 
have only selected those that are in the range of 5.0Å from the substrate (we use the 
following command in VMD to get this selection: “water within 5 of index 5909”). The 
chosen cut-off distance was set to 4.8Å. The results provided by Chem-Path-Tracker 
are illustrated in Figure 12. 
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Figure 12: Most important chemical interactions present in the active site of OSC. 
 
Chem-Path-Tracker was able to show that the oxygen atom that is involved in the 
epoxide protonation is in close contact with Glu455 - a residue that has been shown 
to be essential for the enzyme function95,96. It has also shown that Glu455 is 
stabilized by two hydrogen bonds provided by one cysteine residue (Cys456) and 
one serine residue (Ser454). Chem-Path-Tracker has also revealed that near the 
oxygen are located two water molecules (Wat2814 and Wat2679). The position of 
Wat2814 is strongly stabilized by Tyr587 and by Glu532. Glu532 is further stabilized 
by Ser580. Interestingly, Tyr587 is part of a sequence of 4 tyrosine residues 
(including Tyr707, Tyr704 and Tyr704) that are aligned across the region of the active 
site and interacts very closely with the substrate. These residues are believed to be 
important for the stabilization of the carbocations that are generated through the 
formation of the four rings of lanosterol97,98. 
The result provided by Chem-Path-Tracker demonstrates that the active site of 
OSC is composed by several residues, which have been shown in the literature to be 
important in different steps of the catalytic process. These residues interact with each 
other through a network of hydrogen bonds and this maybe the key that allows the 
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concomitant formation of the four rings that is catalyzed by this enzyme and involves 
an uncommon carbocation chemistry. 
3.2.1.4.4. Identification of Cation-π interactions 
Chem-Path-Tracker can also be extremely useful when seeking non-covalent 
interactions, such as cation-π interaction. This type of interactions has been relatively 
unappreciated when compared to the more conventional interactions such as 
hydrogen bonds, ion pairs and the dispersive interactions, but recent studies have 
shown that they play an important role in molecular biology. In proteins, cation-π 
interactions occur between π electron-rich residues such as tyrosine, phenylalanine 
or tryptophan and an adjacent cationic atom or residue, such as lysine or arginine. 
These interactions are known to contribute to the stability of protein native states, as 
well as protein ligand complexes, or even DNA/RNA complexes but their structure 
and function remains poorly understood99.  
An interesting example of a continuous (cation-π)n stack composed of a large set 
of residues is observed in the X-ray structure of human growth hormone/receptor 
complex (pdb code 3HHR)100.  The identification and visualization of these structures 
is however difficult to make because the protein contains thousands of atoms and 
this type of structure only occurs in a specific region of the protein.  In order to turn 
this process easier we have used Chem-Path-Tracker to visualize them as well as to 
evaluate the nature of the surrounding residues; the user just has to go through a 
couple of steps. The first step involves the selection of a starting point. In this case 
the user has to know one residue that is involved in the cation-π interaction network. 
In this case we selected one atom of Phe225 (index 4524). The next step involves 
the selection of all the potential amino acids around Phe225 that might be involved in 
the (cation-π)n stack chain - we selected all the amino acids that contain rings in their 
structure and all the cationic residues. For this purpose we have inserted two custom 
selections in the Chem-Path-Tracker Data points list: for the first selection we used 
“(resname HIS HIE HID PRO PHE TYR TRP) and not backbone)” and for the second 
selection “(resname ARG LYS GLU GLN) and not backbone)”. We have chosen a 
cutoff distance of 4.5Å.  The final result provided by Chem-Path-Tracker is shown in 
Figure 13. 
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Figure 13: Graphical pathway that was highlighted by Chem-Path-Tracker revealing the (cation-π-)n stack chain 
found on the PDB structure with the code 3HHR. 
 
Chem-Path-Tracker has sketched a straight line across the protein structure that 
connected several node points. These node points are part of an interesting (cation-
π)n stack chain formed by Lys179-Tyr186-Arg211-Phe225-Arg213-Tyr222-Lys215, in 
which the positive charged residues are intercalated with aromatic containing 
residues.  
3.2.1.4.5. Exploring Water Channels  
Aquaporins are proteins embedded in the cell membrane of biological cells that 
form pores and regulate the flow of water. These proteins are very important because 
they have specific characteristics that allow them to be impermeable to proton 
permeation despite their very fast water conduction. The available X-ray structures of 
aquaporins reveal that in the middle of these proteins there are channels that are 
populated with water molecules. These channels are very narrow and constrain the 
access of water molecules, only allowing one water molecule to pass through the 
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channel. Interestingly, this could lead to the idea that this net of water molecules 
could easily act as a proton wire to conduct protons but this cannot occur, as it would 
damage the membrane101. The amino acid residues lining the constriction of these 
water channels are mainly hydrophobic with the exception of some polar amino 
acids. Recent results have shown that the role of these residues is very important 
because they help to line up and orient the water molecules in such a way that 
prevents the proton transfer. 
In this context Chem-Path-Tracker can be extremely useful not only to highlight the 
region that is occupied by the water molecules and therefore to highlight the water 
channel, but also to identify which residues interact more closely with these 
molecules and preclude the proton transfer. In this quest we analyzed the pdb 
structure 2zz9102.   
In order to run Chem-Path-Tracker, the user has to start by selecting a starting 
point. In this case we selected the index of any water molecule located in the water 
channel (for instance index 1858). Subsequently, the user has to select which type of 
residues he wants to search for and that remains in close contact with that starting 
point. In this case we start by selecting the water molecules that are present in the X-
ray structure in order to visualize the form of the water channel (this can be done 
inserting the custom selection: resname HOH). Additionally, we will select all the 
amino acids of the protein in order to identify which residues are in close contact with 
these water molecules (this can be done with the HBonds automatic selection). 
These selections will create a list of points (nodes) in the graphical interface.  The 
last step that is required to start Chem-Path-Tracker is a cut-off distance that will be 
used by the software to constrain the search distance between the node points (in 
this case we used a cut-off distance of 4Å.).  The final result can be seen in Figure 
14. 
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Figure 14: Graphical pathway that was highlighted by Chem-Path-Tracker on the PDB structure with the code 2zz9. 
 
In Figure 14, we can see that Chem-Path-Tracker was able to draw a pathway in 
the middle of the protein that corresponds to its channel. Analyzing the output file of 
Chem-Path-Tracker, we found that the majority of the residues that compose this 
pathway are water molecules, but a small set of them are polar residues, namely two 
asparagine residues (Asn213 and Asn97), an arginine (Arg216) and a histidine 
(His201) residue. 
From the literature it is proposed that the residues that were highlighted by Chem-
Path-Tracker are highly conserved in the aquaporins and very important to prevent 
the proton conduction102. Indeed, it is proposed that the position and orientation of 
these residues allows them to interact through short hydrogen bonds with the nearby 
water molecules103. This effect is proposed to have two consequences: i) the 
transient hydrogen bonds reduce the energy barrier for water molecules coming into 
the middle of the channel, and ii) it forces the reorientation of the water molecules. In 
the former case, it forces the hydrogen atoms to become oriented perpendicular to 
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the channel axis, thus excluding any contact with the adjacent water molecules. 
Consequently, the central water molecule becomes isolated from the other water 
molecules in the channel. As a result, the water molecules no longer act as a proton 
wire, and the channel no longer conducts protons.  
3.2.1.4.6. Proton and electron transfers 
Reactions involving proton and/or electron transfers have always attracted 
considerable attention, mostly because of their wide distribution in many areas of 
biology and chemistry.  
One of these interesting and challenging cases involves the enzyme 
ribonucleotide reductase (RNR). RNR is an extraordinary enzyme that catalyzes the 
conversion of the nucleotides into their corresponding 2’-deoxynucleotides. This 
enzyme is composed by two homodimeric subunits, named R1₂ and R2₂ that have to 
dimerize in order to turn the enzyme active.  Each R1 monomer lodges an active site 
that is responsible for the enzymatic activity, whereas each R2 monomer contains a 
diiron-tyrosyl radical cofactor that is deeply buried in the protein surface. Each 
cofactor is responsible for the generation of a radical that has to migrate to the active 
site that is located almost 35Å away in monomer R1. This subject has been under 
intense research in the last three decades but the atomistic insight of how it happens 
remains unsolved because the X-ray structure of the active dimer is still unknown104.  
In the last 2 decades several site mutagenic experiments on monomer R2 have 
shed some light on this issue and identified several residues that participate in the 
proton and/or electron transfer on subunit R2, namely Y122, H118, W48 and 
Y356105,106.  This pathway has been shown to be dependent on a network of residues 
that interact with each other very closely starting at the metal cluster and ending at 
the protein surface of monomer R2. Taking this into account we have tested Chem-
Path-Tracker to see if it could disclose the network of residues that are involved in 
such proton and/or electron transfer of protein R2 and then correlated the final result 
with the data that is available in the literature. 
In this case we opted to analyze a multi-framed structure of subunit R2 of RNR, 
instead of static X-Ray structures as in the previous examples. Therefore, we first 
performed a classical atomistic molecular dynamics simulation of the full R2₂ subunit, 
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using the AMBER9 molecular dynamics package107. The protein residues were 
described using the parm99 force field and the iron ions of the metal cluster were 
described as Lennard-Jones spheres with a charge of +2.  In all simulations, SHAKE 
constraints were added to bonds involving hydrogen atoms, allowing for a 2 fs 
timestep. The temperature was kept constant using a Langevin thermostat with 
coupling parameter of 1 ps-1. 
In order to disclose the network of resides that are involved in the proton and/or 
electron transfer at protein R2, we selected in the Chem-Path-Tracker GUI one of the 
iron ions present in the metal cluster as the starting point. We then selected all the 
residues that could be involved in a network of hydrogen bonds as well as the 
residues that possess rings structures. In this case we chose a cut-off distance of 
5.2Å and set Chem-Path-Tracker to analyse all the snapshots of the molecular 
dynamics run in steps of 10 frames.  
 
 
Figure 15: Interaction network between the residues of monomer R2 of RNR provided by Chem-Path-Tracker (for the 
clarity of the image, Tryptophan 48 and 211 were not represented). The residues labeled in red were experimentally 
identified by site-directed mutagenesis to be crucial for enzymatic activity (the nomenclature of the residues was 
based on the X-ray structure 1XIK). 
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The results provided by Chem-Path-Tracker are shown in Figure 15.  In this case 
the pathway drawn by the software has several colors. These colors indicate the 
tendency of a pathway to occur during the molecular dynamics simulation. This is 
calculated based on the average of the residues pair distances and the respective 
standard deviations, which were calculated in each frame that was analyzed in the 
molecular dynamics simulation. 
Despite the great simplicity and speed of Chem-Path-Tracker, the algorithm was 
able to identify in the protein structure a network of interactions that start at the metal 
cluster and end at the protein surface.  These networks reveal that the di-iron metal 
cluster is surrounded by a group of negatively charged residues, namely aspartate 
Asp155 and three glutamate residues Glu84, Glu204 and Glu238, as well as two 
histidine residues (His118 and His241) a glutamine residue (Gln85) and a tyrosine 
residue (Tyr122).  These residues should be important to maintain the metals bound 
to the protein scaffold and at the same time provide the chemical environment 
required for the formation of the radical that is required for the catalytic process. 
Additionally, Chem-Path-Tracker has also highlighted a group of residues that 
interconnect this region with the protein surface. This pathway is composed by 
Asp237, Arg238, Tyr358 and Lys42. This group of residues should therefore be 
implicated in the migration of the radical from the metal complex to the surface of the 
protein structure.  Gln43 and Trp48 were also identified by Chem-Path-Tracker but 
their function seems to be more involved in stabilizing the position of Asp237, Arg238 
or perhaps in stabilizing the migration of the radical through these residues. 
Comparing the residues that were marked by the Chem-Path-Tracker algorithm 
and the residues that are known experimentally105 to be involved in the proton 
electron transfer (residues label in red in Figure 8), we can see that there is a very 
good match. Indeed, Chem-Path-Tracker was able to highlight all the residues that 
were experimentally observed by site directed mutagenesis to be involved in the 
proton electron transfer (residues marked with an asterisk in Figure 8). This example 
demonstrates that Chem-Path-Tracker can be a very handy tool to explore the 
protein structure and can be used to help experimentalists to foresee possible 
residues that might be important for protein function.  
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3.2.1.5. Conclusions 
Chem-Path-Tracker was developed to provide a fast approach to identify possible 
chemical motifs in any type of system containing thousands to millions of atoms. 
These structures are often difficult to reveal by the non-expert user or hard to 
characterized to its full extent because they are a small part of the protein structure 
that are not sequential as general alfa-helixes or beta-sheets and they only come 
together when the protein is folded in its tri-dimensional structure. 
The algorithm used in Chem-Path-Tracker relies on a modified version of Dijkstra’s 
algorithm that searches for the closest path between a pre-selected set of node 
points that are pin-pointed by the user. These node points can be amino acids, atoms 
types, or any type of selection that can be identified by VMD. The algorithm starts 
from a pre-selected point chosen by the user and uses a cut-off distance to joint that 
point with all the other node points. In the course of the process this will generate a 
pathway of points. The node points are included or not in the pathway depending on 
the cut-off distance, which means that not all the node points will be part of the 
pathway. If more than one node point fulfills the condition imposed by the cut-off 
distance, the Chem-Path-Tracker algorithm will generate n-pathways and guarantees 
that each pathway is unique. 
The final result provided by Chem-Path-Tracker will always be dependent on the 
conditions that are imposed by the user and therefore they must have a chemical 
meaning. To help the user, the program comes with a pre-defined condition that can 
be used to search for molecular motifs involving hydrogen bonds, ionic bonds and 
cation-π interactions.   
The Chem-Path-Tracker software can be used to analyze static structures, as it is 
the case of the X-ray structures deposited in the protein databank (pdb structure), or 
any other type of structure that can be read by VMD. It can also be used to analyze 
multi-framed structures, such as molecular dynamics simulations whose format can 
be analyzed by VMD. 
The application of Chem-Path-Tracker to the structure of several proteins has 
revealed to be extremely useful. It allows the identification and characterization of the 
structure of active sites, pathways of residues involved in proton and/or electrons 
transfers, or even to look for specific residue interactions, as it is the case of cation-π 
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interactions. Some of these results are capable of highlighting key amino acids that 
were identified experimentally in the past to be crucial for the protein function.  Based 
on these results, we believe that Chem-Path-Tracker can be a very handy tool to 
explore the structure of proteins and speed up the deciphering of chemical motifs in 
biological systems.  
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3.3. VolArea 
Protein structures can determine the type and strength of their interactions with other 
compounds, either small molecules or big proteins. An example that can strongly influence 
the interaction between proteins is the accessibility of certain residues from one of the 
proteins to the other/s protein/s, increasing the probabilities of strong interactions between 
them. Besides the different surfaces that VolArea can evaluate, such as the solvent 
accessible surface or surface accessible to other compounds, the volume of the structures or 
empty volumes such as cavities and clefts can also reveal important information, for 
instance, the space available to the interaction and the behavior of the surrounding 
environment of the binding site when a trajectory is analyzed.  
In order to provide the user with the tool necessary to calculate molecular surface areas 
and volumes, we have developed a computer program named VolArea, a VMD plug-in that 
presents a very intuitive Graphical User Interface, supporting the user in the preparation of 
the values necessary to the calculation, displaying the results in a very simple way and 
evaluating standard deviations and averages in the cases of a multi-frame analysis.     
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Article III 
 
“VolArea - A Bioinformatics tool to calculate the surface area and the volume of 
molecular systems“ 
 
Adapted from: 
Ribeiro J.,Cerqueira N.M.F.S.A., Fernandes P.A., Ramos M. J. 
Chem Biol Drug Des 82:743–755, 2013. 
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3.3.1. VolArea - A Bioinformatics tool to calculate the surface area 
and the volume of molecular systems 
J. V. Ribeiro, J. A.C. Tamames, N. M.F.S.A. Cerqueira, P. A. Fernandes and M. J. RamosREQUIMTE , 
Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, Rua Campo 
Alegre s/n , 4169-007 Porto, Portugal. 
3.3.1.1. Abstract  
We have developed a computer program named VolArea that allows for a rapid and fully 
automated analysis of molecular structures. The software calculates the surface area and the 
volume of molecular structures, as well as the volume of molecular cavities. The surface area 
facility can be used to calculate the solvent-exposed surface area of a molecule or the 
contact area between two molecules. The volume algorithm can be used to predict the space 
occupied not only by any molecular structure but also the volume of cavities, such as tunnels 
or clefts. The software finds wide application in the characterization of systems such as 
protein:ligand complexes, enzyme active sites, protein:protein interfaces, enzyme channels, 
membrane pores, solvent tunnels, among others.  Some examples are given in order to 
illustrate its potential. VolArea is as a plugin of the widely distributed software Visual 
Molecular Dynamics (VMD) and is freely available at 
http://www.fc.up.pt/PortoBioComp/Software/Volarea/Home.html 
.  
Keywords: Surface Area; Volume; Molecular Dynamics Simulation;AMBER; Visual 
Molecular Dynamics 
3.3.1.2.  Introduction 
From the simplest bacteria to the complex human being, proteins play essential roles, 
even viruses depend on them. Like other biological macromolecules such as 
polysaccharides and nucleic acids, proteins are virtually involved in all physiological 
functions, and understanding how they work is a fundamental problem in biology.  In the last 
40 years the atomic three-dimensional structures of thousands of proteins have been 
characterized by experimental techniques such as X-ray crystallography and nuclear 
magnetic resonance, revealing some of the key features that allow them to play unique roles 
in living organisms. One of these key features is their ability to specifically bind other 
molecules. These molecules can be either small compounds, such as low molecular weight 
substrates or inhibitors, or larger biopolymers like DNA, RNA or other proteins. 
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Understanding how large chemical structures bind each other and how small molecules bind 
to larger chemical structures with high affinity and specificity, has become a subject of 
paramount importance for the understanding of structure/function relationships in biology. 
For a possible interaction between a ligand and a receptor to take place, it is necessary 
that there is enough space for the binding to occur, i.e. it is necessary that the ligand fits 
inside the binding site; to predict if the binding will occur with high affinity it is necessary to 
know which set of residues will interact more strongly with the ligand. These two 
characteristics can be determined, at least partially, by the volume of molecules and their 
cavities and the contact area that they share.  The molecular surface area calculation can be 
applied also to evaluate different molecular properties, especially when the calculation is 
targeted to the property intended to evaluate. For instance, surface area calculation adapted 
to the atoms type can be used to calculate ADME (absorption, distribution, metabolism, 
and excretion) parameters such as the partition coefficient (logP)108, the contribution of this 
surface to the entropy term in the protein-protein interaction109 and the solvation energy110. 
The advantage of these methods when compared with others such as Thermodynamic 
Integration (TI) or the Poisson-Boltzmann/Generalized Born Surface Area is the 
computational efficiency achieved where only surfaces areas are calculated.  
In the last 5 years, several computational algorithms have emerged to calculate the volume 
and the surface area of molecular structures. However, despite the developments and the 
improvements carried out by these softwares 111-116, there is still much room for improvement, 
mostly in terms of quantifying the volume and surface, establishing multi-frame structure 
analysis or even through the development of molecular visualization interfaces. Table 1 
summarizes the main characteristics of the most used softwares that perform this kind of 
calculations.  
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Table I - Summary of the software’s available for calculating the volume and the surface of structures. a) Finds and 
assigns the routes of tunnels; b) Finds binding sites using protein sequence; c) Uses the surface algorithm to 
calculate the volume using Monte Carlo; d) Grid-based method used to find and characterize binding sites and pockets 
(cavities), using both the surface area and volume as parameters; e) Visualizes channels and tunnels f) Uses the same 
algorithm to calculate the surface and the volume. 
Characteristics 
Software 
Caver111 PocketMatch116 McVol114 MDpocket115 HOLLOW112 3V 117 
Volume - - a a - a 
Surface - - a a - a 
Multi-frame 
Analysis - - a a - - 
Main features a) b) c) d) e) f) 
Molecular 
Viewer 
PyMol11
8 - - - - - 
 
In this work we describe VolArea, a new bioinformatics tool developed not only for 
analyzing molecular structures, such as proteins and nucleic acids, but also molecules of any 
size or nature. The program has been included into the widely distributed Visual Molecular 
Dynamics software (VMD) 31 as a stand-alone plug-in that provides a rapid, accurate and 
fully automated process to calculate the surface area 119 and the volume of any molecular 
structure. VolArea overcomes most of the limitations of the pre-existing software and 
provides a very intuitive and useful interface to study the structure of protein complexes, 
such as protein:ligand or protein:protein complexes, or even membrane pores or nucleic 
acids. 
3.3.1.3. Methods 
VolArea is a multiplatform application to calculate the surface area and the volume of any 
molecular structure. The full procedure is divided into two main algorithms, the surface area 
and volume algorithms described in the following sections. The VolArea graphical user 
interface (GUI) manages and displays all the data required and generated by VolArea. This 
GUI will also be described in the following sections.  
One important characteristic of both surface area and volume algorithms is their 
dependence on the selection of atoms. This selection defines the universe in which the 
algorithms will be applied. Throughout the Application Section this dependency will be 
explained and clarified. 
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3.3.1.3.1. The Surface Area Algorithm 
The surface area is calculated making usage of the algorithm developed by Futamura et 
al.120, which has been already implemented in the VMD program 31 as a command named 
measure sasa. VolArea intends to present here a new possibility for large-scale applicability 
and non-expert use of this command. Until now, the algorithm is only available as a 
command line, which becomes difficult to use for non-experts and difficult to apply in large 
sets of residues or structures even for experienced users. Using this plug-in, the user can 
calculate the surface area of any structure (not only residues), exposed to the solvent or in 
contact with other structures, such as small ligands, or even exposed to protein sub-units. All 
these calculations only require simple small atoms selection and a few clicks.  
The surface area calculation depends on the selected area, on the probe radius, and on 
the number of points that are used to compute it. The probe radius can be defined as an in 
silico rolling spherical probe that is screened around the selected area. The surface formed 
by the rolling sphere above the molecule is the exposed surface area (Figure 16).  
The default radius value of the probe sphere is 1.4 Å (the radius of a water molecule) and 
50 points are used to estimate the solvent accessible area, but other values can be used to 
investigate other type of interactions.  
 
Figure 16: Illustration of the usage of the probe radius to calculate the surface of molecules. 
 
In the end, the surface values are displayed in the GUI, as the total area of the selected 
region and the area of each residue defined by VMD. A statistical analysis of the surface 
values is also performed when two or more frames are available in the structure file (e.g. 
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molecular dynamics simulation).  In this case the GUI presents the average value of the 
surface area, the per residue surface area, and the respective standard deviations (total and 
per residue). In multi-framed structures the GUI also creates a surface area vs frame number 
graphic.  
3.3.1.3.2. The Volume Algorithm 
To begin with, the user defines a “selection region”, which is the region of the molecular 
system, which he wants to calculate the volume of. It can be the entire molecular system or 
just a smaller fraction of it. The “selection region” always corresponds to a rectangular 3D 
box. All atoms that are inside the box are selected.  
Additionally, all atoms outside the selection region, closer than 4Å from the edges of the 
selection box, will get selected too. The reason for including these atoms is that the tools for 
selecting atoms in VMD (and in most software) use the nuclei coordinates, and not the van 
der Walls (vdW) volumes. This means that if a given atom is partially inside the selection 
region, but its nucleus is not, it will not be selected, which is undesirable. 
Subsequently, the selected region is divided in a grid of small cubes, and their side 
corresponds to the scale parameter, which is chosen by the user. Therefore, the volume of 
the cube is given by scale3. 
 The size of the cubes must be much smaller than the van der Waals radius of the atoms. 
Therefore, each cube may contain either a single nucleus or it can be simply empty. If the 
cube contains a nucleus, then the nucleus is centered in the cube, and the algorithm 
searches for the cubes that are within the vdW radius of the atom. All the cubes that are 
within the atom radius are marked as “occupied” by that same atom. Otherwise they are 
marked as “empty”. 
If the user intends to calculate the volume of a specific molecular structure, he might not 
want to include any surrounding atom beyond the selection region, which e.g. may belong to 
another molecule close by. In that case the user can choose additional selection tools to 
specify more strictly, beyond the simple distance criteria, the atoms that he/she wishes to 
select. 
The molecular volume is calculated by adding the volumes of all the small cubes marked 
as “occupied”. 
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Figure 17: Schematic illustration of the searching radius superposition in order to illustrate the volume algorithm. 
The total volume of a molecular structure should include small spaces between the atoms 
as well. Figure 17 depicts schematically those small spaces that exist between the atoms 
(when they are defined as spheres with vdW radius). These small spaces exist in any 
structure but they are smaller in crystalline materials or metals. They are particularly relevant 
in protein structures, where the atoms are not spatially very organized. Such small volumes 
are too tiny to be occupied by any atom/molecule. They are in fact “inaccessible” and this is 
why they should be included in the total volume of the molecular structure.  
To include them, we further searched for the cubes that are located in a spherical shell, 
centered at the nuclei, having as lower and upper limits the vdW radius and 1.5 times the 
vdW radius (Figure 17). If a cube belongs to the spherical shell of, at least two atoms, it is 
included in the total volume of the molecular structure.  
The calculation of the volume of cavities is conducted in a slightly different way. The 
search for cubes that belong to a cavity is performed with another probe radius, named 
“Cavity Probe Radius”, centered in the atomic nuclei. The radius of the cavity probe will be 
chosen by the user, according to the shape and size of the cleft or pocket. In fact, the user 
must choose the region in which he will be searching for a cavity, distinguishing between a 
“cleft” and “bulk solvent”, before the calculation takes place, in the same way as the user 
must select a region to calculate a molecular volume before the algorithm calculates its 
value. The cavity probe radius will be the tool defining the region to be analyzed for cavities. 
Subsequently, the volume of the atoms is expanded from the vdW radius to the cavity 
probe radius. This is done assigning the value of “occupied” to all cubes within a sphere, 
centered in each nuclei, and having a radius given by the cavity probe. The cubes that are 
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within the cavity probe radius of more than one atom are assigned as “cavity cubes” and the 
final volume of the cavity corresponds to the sum of the volume of all cubes assigned as 
“cavity cubes”. (Figure 18).   
 
Figure 18: Example of the searching radius superposition, here applied to the cavity volume calculation. 
The shape of the cavity may exhibit small irregularities in its borders, i.e. 
depressions/pockets so small that cannot accommodate any atom. The algorithm further 
searches for these very small surface pockets and eliminates all those that are smaller than 
the volume of a hydrogen atom (around 5 Å3).  This elimination is accomplished by searching 
1 Å in each direction of the current position, creating a search matrix with 8 Å3, which is large 
enough to include an hydrogen atom. In if the total empty space volume is small than the 
hydrogen atom volume, the current position is unmarked, disabling it to be part of the main 
cavity. The volume algorithm is resumed in Figure 19.  
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Figure 19: Diagram of the algorithm that is used to calculate the volume in VolArea.  
If the input is a multi-frame structure the algorithm processes all the molecular 
conformations sequentially and presents the average and the standard deviation of the cavity 
volume or molecular volume, in the same way as it did with the surface area algorithm. 
These values can be represented also in a volume vs frame plot. Once this procedure has 
been completed, the final results are stored in a structured SQLite database 
(http://www.sqlite.org/) that can be used subsequently by the user for further analysis or data 
manipulation through standard SQL functions.  
VolArea was developed with TCL/TK as the programming language and is available as a 
plug-in of VMD, version 1.8.7 or higher. This software requires a TCL shell installed in the 
host machine as well as the thread package. The version of this package depends on the 
type of operating system, i.e. for both windows and macOS operating system machines it is 
required the TCL shell version 8.4(32 bits) and tcl-thread package (2.6 or higher); for linux 
operating system machines, the TCL shell version 8.5(32 or 64 bits) and tcl-thread package 
(2.6 or higher) are required. All these package are freely available at 
http://www.activestate.com/activetcl/downloads. 
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3.3.1.4. RESULTS AND DISCUSSION 
We start by validating the VolArea algorithm, by comparing the calculated molecular 
volume against experimental values121. Afterwards, we describe the Graphical User Interface 
(GUI) and exemplify some possible applications of this software, showing how it can be used 
to get insights into the physical properties of biochemical systems.  
3.3.1.4.1. Validation 
In order to validate the volume algorithm implemented in VolArea, we have calculated the 
volume of eleven proteins, and compared the results with experimental data 121. The pdb 
codes of the structures used in this test were: 4pti122;3rn3123; 1lzt 124; 5mbn125; 3adk 126; 1ppn 
127; 1rei 128; 2cna 129; 3est 130; 1rhd 131 and 2ctb 132.  
We have used the Open Babel software 133 to add hydrogen atoms to their X-ray 
structures. Then we have calculated the protein volume with VolArea using different scale 
values (grid cubes sides). Finally, we have compared the results with the experimental 
values and evaluated the relative errors. All the protein structures had all residues defined in 
the pdb files. Figure 20 summarizes the results. 
 
Figure 20: a) The relative error in the protein volume calculation (defined as the difference between the experimental 
and calculated volumes divided by the experimental volume) vs. the scale value and b) the average and standard 
deviation of the relative error for the 11 structures calculated. All results are presented as percentages. 
   FCUP 
COMPUTER-AIDED DRUG DESIGN - Lead Discovery 
87 
 
Figure 20 shows that the influence of the scale value in the calculated volume was 
approximately the same in all tested proteins. The maximum deviation was 18.6 percent with 
a scale value of 1.0 Å in the 3rn3 structure and the minimum value was 0.11 % with a scale 
value of 0.7 Å in the 5mbn structure.  
To understand how accuracy (i.e. the relative error in relation to the experimental value) 
depends on the total volume of the protein we plotted the values obtained before and 
presented them as a function of the experimental protein volume (Figure 21). The results do 
not show any direct correlation between them, meaning that the deviations are not 
systematic. Therefore, the algorithm accuracy is independent of the size of the molecular 
structure. Figure 6 indicates that the deviation is between 0 and 3.0 % at 0.7 Å scale.  
 
Figure 21: Variation of deviation as a function of the protein volume with a scale of 0.7 Å. 
Note that the deviation of the calculated values from the experimental ones arises in part 
from the fact that the experimental volume reflects an average over many conformations. On 
the other hand, a single pdb structure was used in the calculations for each particular case. 
However, the x-ray structure incorporates implicitly an average folding over many molecules 
in the crystal, but in the end the atom positions in the pdb files must be fitted to just a single 
stable minimum energy conformation. Another source of deviation is the scale used in each 
test. We have limited the scale values to a range between 1.0 and 0.7 Å because within this 
range the accuracy increased almost linearly with the decrease of the scale parameter. For 
scales smaller than 0.7 the accuracy changes in a non-systematic way due to the set of 
approximations of the algorithm, which was designed to produce very accurate results with 
large scale values for improved computational performance. 
In fact it is desirable to include all the scales values between 1.0 and 0.1, which is 
impossible due to the computational demanding that makes it intractable. The error 
associated to the limitation of the scale to the values between 1.0 and 0.7 are canceled by 
the usage of the 1.5 multiplier in the van der Waals overlap search algorithm. The results 
observed in the Fig 20 reveal the non-fortuitous behavior of the algorithm, reflected in the 
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good agreement in the tendency of the error in terms of volume percentage in function of the 
scale. 
The code was parallelized to enhance the performance of the volume algorithm, in 
particular when processing multi-frame structures from computer simulations. Figure 22 
shows the speed up of the process using two or four processing cores. All calculations were 
performed in a quadcore machine (Intel Core 2 duo 2.66 GHz with 4 Gbytes of RAM). 
Calculation times refer to the time of the volume calculation only, excluding the time spent in 
representing graphically the volume in the OpenGL VMD window, since this representation is 
performed only once independently of the number of frames analyzed. The time shown for 
each protein in Figure 22.a. is the average time for the calculation of the volume taking into 
account all scale values tested before (1.0; 0.9; 0.8 and 0.7 Å). In Figure 22.b, the ratio of 
time in the volume calculation is presented using two (2C) and four (4C) processing cores. 
Here, the values correspond to the time average (in seconds) of the volume calculation, vs. a 
given scale parameter. The parallelization performance was almost the same whatever the 
resolution of the protein used. 
  
 
 Figure 22: a) Average of the times of the protein volume calculation (using scale values from 1.0 to 0.7 Å) using four 
processing cores (4C) as a function of experimental volume, b) ratio of the times in the volume calculation using two 
(2C) and four processing (4C) cores. The speed up is linear. 
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The time required to calculate the protein volume grows with the protein volume, as 
expected (Figure 22.A). It should be noted that the difference between the smallest (7800 Å3) 
and the largest protein (42000 Å3) corresponds to less than 20 seconds, independently of the 
resolution.  
In this analysis it is possible to see that the user saves 50% of computing time duplicating 
the number of cores (linear speed up) (Figure 22.B), and this ratio was observed in all 
proteins studied.  
3.3.1.4.1.1. Graphical Interface 
In order to generalize the application of these algorithms and to make it available to a 
wider audience, we developed a GUI in Tcl/Tk 134 that was included in VMD as a plug-in  
(Figure 23).  We have chosen VMD because it is an extremely powerful molecular viewer 
that represents the structure of the molecules in a wide range of formats and is very handy to 
perform many structural analyses.  In addition, VMD is a very flexible program that can be 
used to display all the data generated by VolArea. This is extremely important because both 
the surface and the volume can be difficult to visualize if not displayed in three-dimensions 
together with the molecular structures. 
All the variables that control the execution of the surface area and the volume algorithms 
can be manipulated in this GUI (Figure 23-A). To make the calculations faster, the GUI 
contains a selection module that restricts the region of analysis (global and specific 
selections in Figure 23-A).  The region can be selected through a yellow box that can be 
interactively handled by the user (Figure 23-A). In addition, the user can make use of a set of 
selection tools to specify more closely what he/she wishes to analyze. For instance these 
tools can be used to calculate the volume of a cavity occupied by a ligand (Figure 23-A). 
These selections can be of any of the types recognized by VMD.  
All the results generated by VolArea are stored in a unique file that has a SQL database 
format.  The same GUI can be used to analyze the results (Figure 24-B) or the data can be 
exported to other applications for further analysis. In the case of multi-frame structures the 
program also provides a graphic visualization of the variation of the surface and volume 
during a trajectory (Figure 23-B). 
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Figure 23: VolArea Graphical interface:  (A) The Input tab is the main window of the program - where the calculations of 
the surface and the volume are set and where the user defines the area that he/she wishes to analyze. (B) The Output 
tab is where the results are presented/analyzed or can be exported to other programs. (C) The About tab provides 
information on the VolArea plug-in (D) The graphic window is part of the output tab and allows the user to plot the 
results produced by VolArea. 
 
 
 
 
   FCUP 
COMPUTER-AIDED DRUG DESIGN - Lead Discovery 
91 
 
3.3.1.4.2. Applications 
Here we describe the potential of VolArea and how it can be used to get insights into the 
physical properties of biochemical systems. 
The surface area measures the exposed area of a molecular structure.  It can be used to 
calculate the solvent accessible area of a molecular surface or the contact area that is 
shared between two or more chemical structures that are tightly bound, such as 
protein:ligand complexes, protein:protein complexes, protein:DNA complexes, etc. In the 
case of proteins, VolArea provides the individual contribution of each residue for the total 
surface area. This information can then be used, for instance, to map all the residues that are 
present in the analyzed surface according to their exposure to the medium and to identify 
important electrostatic characteristics in binding sites. 
The volume tool can be used to estimate the three-dimensional space that a molecular 
structure occupies as well as the free volume in a pre-selected region. The latter can be used 
to calculate the volume of internal cavities, surface clefts of proteins, as well as the free 
space between two interacting molecular structures such as protein:protein interfaces, 
protein:membrane complexes, protein:DNA complexes, etc. It finds wide application in 
predicting if a ligand fits inside the binding site of a protein, a pre-condition to select 
candidates for drug discovery programs. 
Estimating the value of the surface area and of the volume can be a tricky job as it is 
largely influenced by the specific molecular conformation considered. Taking this into 
account, VolArea can calculate the surface area and the volume of single structures (such as 
the ones retrieved from X-Ray structures) as well as ensembles of structures (retrieved from 
molecular dynamics or Monte Carlo simulations as well as from Nuclear Magnetic 
Resonance (NMR) spectroscopy). In all cases the source data can assume any of the file 
formats that can be handled by the VMD software. This means that the user can use this 
software without any previous conversion or manipulation of the source data.  PDB, mol2, 
xyz and other file types handled by VMD are well supported by VolArea, as well as multi-
frame structures that are retrieved by popular molecular dynamics applications such as 
AMBER135, GROMACS136, CHARMM137, or NAMD138, among others.  
In order to generalize the application of these algorithms to any problem, and to make it 
available to a wider audience, VolArea is distributed with a graphical user interface (GUI). 
The developed GUI has several modules that ensure a smooth execution of the program, 
requiring only minimal user intervention, such as selecting the area of the chemical structure 
that the user whishes to analyze. All the generated information is displayed on the graphical 
interface and on the VMD backend, but may also be exported to other programs for further 
analysis. 
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To demonstrate the potential and usefulness of this application, we present a set of 
examples involving proteins and small molecules. VolArea can handle isolated structures 
such as proteins, membranes, polysaccharide chains, DNA, etc., but also complexes made 
up of several proteins (protein:protein complexes) or of different chemical structures, such as 
protein:ligand complexes, protein:DNA complexes, protein:membranes, etc.  In the latter 
cases, the program is even prepared to study each unit independently, which can be useful 
to derive structural information from the interaction between both subunits. 
The examples that are described in the following sections are arranged in two groups: the 
static structures and the multi-framed structures. 
3.3.1.4.2.1. Static structures assay  
VolArea can be used to analyze the interface between two or more proteins.  There is 
great interest in the identification of the residues that control the association and the 
interaction between proteins. It is known that just a few residues contribute for most of the 
binding affinity. The identification of these residues is not straightforward, but often they can 
be pointed out by the recognition of structural features that are indicative of their importance 
in the binding. This type of analysis can be performed by VolArea, using its selection tools 
and exploring the surface area in the interface region between the binding proteins. The 
resulting information can then be used to visualize the complementarity of the residues that 
are present on the protein interface and to understand which type of regions might be 
important for protein interaction. One example of such analysis is shown in Figure 24. 
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Figure 24: Surface values obtained with VolArea while analyzing the interface region of two proteins (retrieved from the 
PDB structure 1VFB): A) Protein complex; B and C) representation of the interface region of each protein (colored by 
residue polarity - non-polar residues (white), basic residues (blue), acidic residues (red) and polar residues (green)), 
with the identification of the hot, warm and null spots with colored circles; D) and E) The buried area upon dimerization 
for each of the interfacial residues. The hot spots are colored red, the warm spots are colored orange and the null 
spots are colored yellow.   
This analysis was applied to the protein complex composed by two proteins: the hen egg 
lysozyme and the immunoglobulin (Figure 24A, PDB entry: 1VFB 139).  In order to identify 
which residues are more important for protein binding, we explored the interface region of 
each protein and calculated the buried area upon dimerization. The importance of the 
residues in a protein-protein interface can be reflected in the binding energy variation upon 
mutation by an alanine residue, where a residue mutated by an alanine that implies a 
variation of the binding energy between 4 and 2 kcal/mol is denominated a hot-spot; a warm 
spot is associated with a variation in the binding energy between 2 and 0 kcal/mol and a null 
spot is associated with a variation in the binding energy below 0 kcal/mol140,141. For this 
purpose, we started by calculating the exposed surface area for all residues located at the 
interface region, as if the proteins were dissociated from each other. Subsequently, we have 
subtracted this value to the exposed surface area of those resides when the complex is 
formed.  The buried surface upon complexation is a very important property because it has 
been shown before142 that to have a very small area exposed to the solvent in the complex it 
is a necessary (but not sufficient) condition for a residue to behave as a hot spot.  
This can be easily done using the set of selection options that are present in the VolArea 
graphical interface. The results are depicted in Figure 24D-E, and show that the residues that 
bury the most upon complexation are Tyr101, Asp100 and Gln121. These results are very 
similar to those obtained previously by experimental and computational means, in which 
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those residues were identified as hot (Tyr101) and warm spots (Asp100 and Gln121)27,139. 
Besides those residues, VolArea has also identified other amino acids that present a 
significant fraction of their area buried upon complexation, when compared to the dissociated 
form (but in lesser degree than the previous ones), namely Tyr32, Trp92 and Arg125. These 
residues were not identified as hot or warm spots. On the contrary, they were correctly 
identified as null-spots 27,139. This confirms that a hot spot is buried in the interacting subunit, 
but a buried residue is not necessarily a hot spot. 
 This small, but illustrative example shows that VolArea can be used to highlight important 
regions of protein interfaces that can be crucial for their association/interaction.  This means 
that it can be a useful tool to assist the screening of proteins interfaces in the quest of finding 
hot and warm spots, as a first approximation, and to help the experimentalist to choose the 
residues more suitable to carry out site-directed mutagenesis, avoiding long and costly 
mutations of residues that we can predict that cannot be hot-spots. 
3.3.1.4.2.2.   Multi-framed structures assay 
To demonstrate the potential of VolArea in analyzing multi-framed structures, we checked 
the results obtained from a molecular dynamics simulation that was obtained in a previous 
work 37,143. The system presented here simulates the interaction of cellohexaose with the 
carbohydrate-binding modules (CBM) from family 11. The CBM 11 proteins belong to the 
cellulosome multiprotein superstructure. The main function of these proteins is to increase 
the efficiency of the enzymes that hydrolyze cellulose, by detaching cellulose strands from 
the cellulose network, breaking the hydrogen bonds between them and guiding them to the 
inner location of the protein/enzyme consortium, where the hydrolytic enzymes are located 
143.  
The initial structure of this complex was obtained computationally by molecular docking 
with our software MADAMM38. The obtained complex was subsequently relaxed by a 
molecular dynamics simulation of 2 ns. The final results suggested that the binding of 
polysaccharides needed to be preceded (or induced cooperatively) by a conformational 
rearrangement of several residues of the active site, in particular of a set of tyrosine and 
aspartate residues. In spite of being small, these changes led to a significant modification of 
the binding site. There was good agreement between the induced-fit binding pose and 
experimental NMR results 37,143. At the time, it was difficult to follow and characterize these 
conformational modifications of the binding site, but now VolArea provides an excellent tool 
to perform this task. Accordingly, we first started by calculating the changes on the volume 
and on the exposed area of the binding cleft.  These surface values were calculated 
excluding the contribution of the polysaccharide (ligand) in the region of the binding site, and 
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centering and resizing the selection box using the ligand dimensions. In the case of the 
calculation of the volume of the binding cleft, the box was centered and resized in the ligand 
as in the previous calculation, decreasing the dimensions to make sure that only the cleft 
volume was calculated (box dimensions of 16.87 Ǻ width vs 16.06 Ǻ height vs 20.10 Ǻ 
depth). We used a resolution of 1.0 Ǻ and a cavity probe radius of 5.0 Ǻ, to guarantee that all 
the cleft was analyzed throughout the simulation, covering the variations in the binding cleft 
width. The final results are shown in Figure 25. 
 
Figure 25: A) Exposed surface area of the residues located at the protein interface that interact more closely with the 
ligand. B) Snapshots of the MD simulation during the ligand-induced closing of the binding cleft. C) Total exposed area 
of the binding cavity through the molecular dynamics simulation, D) Volume of the binding cavity through the 
molecular dynamics simulation. 
The values obtained with Volarea show that at the beginning of the simulation, the volume 
of the binding site decreases at the same time that the exposed area of the binding site 
increases. Subsequently, they remain almost constant (in particular the volume of the binding 
cavity), which indicates that the system becomes equilibrated in this respect. In fact, the 
decrease in the volume and the increase in the exposed area of the binding site indicate that 
the binding site shape changes to allow for the establishment of a larger number of contacts 
with the ligand.  This is very interesting since it indicates that during the simulation the 
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binding site closes and embraces the ligand, probably improving protein:ligand affinity, a 
perfect example of the induced-fit paradigm. This is most of the time difficult to detect visually 
in the molecular dynamics simulation, but now it can be easily analyzed both qualitative and 
quantitatively with the data provided by VolArea.  
As VolArea provides the individual contribution of the exposed area of each amino acid 
that is present on the protein surface, we analyzed these results and searched for the 
residues that were interacting more closely with the ligand. The results are depicted in Figure 
10 and show that the residues that interact more closely with the ligand are four tyrosine 
residues (Tyr20, Tyr 51, Tyr127 and Tyr150) and several polar amino acids (Asp49, Lys90, 
Asn93, Asp97, Arg124, Asp126, Asp144). These results agree with our previous results and 
with what is observed experimentally 37,143.  However, in our previous study this type of 
analysis was made with a set of complex scripts. Now with only a few clicks we can extract 
this kind of information, and visualize it with the powerful back-end of VMD.  
3.3.1.5. Conclusion 
We have developed the VolArea plug-in to compute the surface and volume of molecules 
as well as the volume of cavities and clefts. This small but agile VMD plug-in has revealed 
itself as a very useful tool in molecular surface area and molecular volume analyses. The 
inclusion of this program in the molecular visualizer VMD will contribute to an easier and 
more general usage of VolArea. Despite not being revolutionary, the possibility of application 
of Volarea to this kind of analyses in large scale multi-frame structures and its friendly 
graphical interface makes it very useful for the community working in the field.   
This package calculates the volume of clefts and tunnels, and maps all the direct contacts 
between molecules in a molecular complex. Currently, these properties could only be 
obtained through a set of complicated selections, scripts and programs, but with VolArea 
they can be easily calculated with a single program, which offers a friendly graphical 
interface that can be used almost by everyone without requiring any previous knowledge in 
the field. Furthermore, the resulting information can be visually analyzed using the powerful 
graphic backend of VMD. 
VolArea can be used to analyze static structures and to analyze multi-framed structures, 
such as those obtained from molecular dynamics simulations. Here, it is possible to follow 
the variation of the exposed surface area of proteins (or other chemical compound) and the 
variation of the volume of the binding site cavity throughout the full simulation. The final 
results provide meticulous data about how these properties progress in time, and can be 
directly visualized with the VMD graphical backend. These results show that VolArea can be 
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used as a new and very useful tool to analyze the trajectories of molecular dynamics 
simulations 
  
   FCUP 
COMPUTER-AIDED DRUG DESIGN - Lead Discovery 
98 
 
3.4. VolArea and CUDA 
Despite the good results described above, it was clear that this software, VolArea, had a 
great potential for improvements, especially in the computational time required by the volume 
algorithm. To provide this software of a faster volume calculation method, the algorithm was 
adapted to the new technology specialized for the computational demanding calculations, 
which is based in highly parallelized codes running in Graphics Processing Unit (GPU). The 
usage of GPUs in molecular simulations or for molecular studies purposes has produced 
good results, being adapted as an ordinary tool in these kind of computational technics25,144-
147. The generalized usage of these units for extremely demanding calculations has being 
supported by programming languages such as Nvida CUDA (Compute Unified Device 
Architecture) and OpenCL. General gains retrieved from GPUs in Molecular studies and 
additional considerations are presented in John Stone et al. publication148 and for more 
information, is advised the reading of the CUDA Manual 149. The general scheme of the GPU 
architecture is presented in Figure 26, where is important to highlight the single processing 
units “streaming multiprocessor” (SM), which are composed by numerous small processing 
units “streaming processors” (SP) in which the threads are performed. In this figure is also 
possible to visualize the different levels of memories, where the local SM cache memories 
present a faster memory access than the global and Level 2 Cache Memory. 
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Figure 26: Simple representation of the NVIDIA Fermi GPU architecture. “A simplified hardware block diagram for the 
NVIDIA representing the arithmetic units “streaming processors” (SP) and “special function units” (SFU) for 
computing especial algebraic functions. Memory load/store units (LDST), texture units (TEX), fast on-chip data caches, 
and a high-bandwidth main memory system. Groups of 32 SPs, 16 LDSTs, 4 SFUs, and 4 TEXs compose a “streaming 
multiprocessor” (SM). One or more CUDA “thread blocks” execute concurrently on each SM, with each block 
containing 64 to 512 threads 148. 
In terms of the programming skills, CUDA programming language allows the programmers 
to apply GPU technology in their work in a well familiarly environment like C programming 
language, instead of the traditional graphics dedicated programming language like OpenGL. 
CPU-GPU codes are very similar to an ordinary C, C++ or Fortran code, adding only some 
demanding operations such memory transference. The GPU code itself has small differences 
inherent to GPUs, presenting at the same time a small period of training and learning. It is 
also possible to apply functional libraries containing several important and useful pre-defined 
functions like THRUST(http://docs.nvidia.com/cuda/thrust/) or CUDA Math library, very 
important for programmers that include these kind of libraries in their codes for arithmetic 
operations improvement and code simplification. One of the drawbacks of GPUs usage is the 
implicit hardware dependency that requires extremely attention in the development routines, 
which leads to several recommendations for maximum code boost from these hardware 
units. One of these recommendations deals with the reorganization of the variable values 
and how the variables are created. Here the maximum independency of the variable values 
is advisable and the sequential organization of the variables in classes or templates is also 
advisable in order to extract the maximum transference speed of information and efficiency in 
the memory access. It is based in these requirements that the VolArea algorithm was 
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adapted in order to take advantage of GPUs capabilities. The approach adopted in this work 
is based in the cutoff potential algorithm published in 150.  
3.4.1.1. Data Structure 
One of the keystones for the development of GPU accelerated algorithms is the data 
structure. The optimization of the GPU code is achieved when the memory accesses are 
minimized and memory transferences between CPU and GPU are optimized. In the 
published work, the volume of the atoms was constructed by searching in the three spatial 
axis(x,y and z) for positions between the center of the atom and the van der Waals radius. 
Here, additional radius is added in order to find small spaces between the atoms, which can 
be part of the molecular volume. This search algorithm is performed by construct a search 
matrix for each atom, where the center of the search matrix is the center of the atom and the 
width, height and depth of the matrix have the dimensions of 3 times the van der Waals 
radius. In each grid position, the distances are calculated to evaluate if it is part of the volume 
or not. In this way, the search algorithm is dependent on the atoms creating a high degree of 
interdependence between the tested position and the atom center. This dependency must be 
avoided in order to adapt the algorithm to GPUs. 
The GPU version of this algorithm has the same algorithm of the previous work, changing 
only how the distances are calculated and their dependency on the atoms center. In this new 
version, the atoms are gathered into bins, which are calculated based on their positions and 
based on a cutoff distance that associates the atom and its bins (Figure 27). For instance, if 
the cavity search radius chosen by the user is 5 Å, thus these bins will have the dimension of 
5x5x5, calculating which atom belongs to each bin as exemplified for coordinate X in 
equation (14):  
 
 !!"# != ! !!"#$ !+ !"#$%&#"'()!"#$%%!!"#$%&'( ∗ !"#$%! (14)  
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Figure 27: Schematization of the organization of the atoms in bins. Here, the red square is highlighting the atoms bin 
with the index 1. The yellow square is highlighting the bins that despite of being empty, they are taken into account 
due to the atom proximity, and the blue square are highlighting the volume excluded from all volume calculation.  
In (14) the ScaleFactor is used to adapt the coordinates to the chosen grid Scale value 
and to avoid exceptions from out of limits references. This factor is translated by the equation 
15: 
The !"#$%&#"'() is equivalent to the cavity search distance !!"#$%& added to the maximum 
van der Waals radius !!"# multiplied by the 1.5 as explained in the previous VolArea volume 
algorithm, and adds 1 Å to create “vacuum” around the protein to avoid out of the limits 
errors originated in rounding operations. 
In the case of VolArea, this cutoff distance is the search distance defined by the user as 
cavity search radius, or, if only the atoms volume is intended, the cutoff distance adopted is 
the 1.5 of the maximum van der Waals radii. This organization allows the search algorithm to 
be only dependent on the grid position that is currently being tested. Here, this grid position 
will be referred to an atoms bin, and then, only the atoms inside of this bin will be tested, 
calculating the distances in order to evaluate if it is equal or shorter than van der Waals 
radius of one of these atoms. If the atom is located in the border of the bin, one ore more 
neighbor bins are selected and the correspondent atoms are tested. 
Besides the faster access memory printed by this atoms bin approach, this same 
algorithm can save memory and time by intensifying processing work where it is needed. For 
instance, if the atoms are sorted by their bins position, and only the non-empty bins were 
 !"#$%&#"'()! = ! !!"#$%& + !!"# ∗ 1.5 + 1 ! (15)  
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carried out for the distance calculation functions of the algorithm, the hardware memory 
alignment required is achieved and the empty spaces far from the atoms are excluded.         
Implementing this data organization and transferring only the atoms center coordinates to 
GPU memory, each grid position can be treated as a single thread in the SP unit increasing 
tremendously the speed of all calculation. Higher efficiency is achieved, as mentioned 
before, when the memory transfers are minimized. In this algorithm this premise is fulfilled 
when only the molecular volume value, cavity volume value and representation coordinates 
are retrieved form GPU. All intermediated values are kept in GPU memory or even erased, 
and the CPU performs the management and instructions for these values.  
3.4.1.2. Results 
 
To test the gains of GPU version against the CPU version, a simple test were carried 
where the time of the GPU required to calculate the molecular volume were compared with 
the new C++ version of the volume algorithm. This test was performed against the previous 
pdb structured tested in the published version: 1lzt 124; 1ppn 127; 1rei 128; 1rhd 131 and 2ctb 132 
and the 1vdv151. The inclusion of the 1vdv pdb structure is justified by the number of atoms 
(42000) and their volume (approximated 350,000 Å3 calculated with VolArea), making this 
structure a good example to demonstrate the GPUs potential. 
 
 
Figure 28: Chart displaying the gains retrieved from GPU. This test reflects how many times is GPU calcualtion faster 
than CPU version of the same algorithm. The test was conducted in a NVIDA GPU prototype, equivalent to the new 
NVIDIA Tesla K20. 
The chart presented in Figure 28 reflects the advantages of using the GPU for the very 
computational demanding operations. The gains are presented in terms of times faster, 
reaching almost a score of 45 times faster when GPU version is compared with the CPU 
version. The abrupt increase between 42,000 and 350,000 Å3 is a clear sign that as the 
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system size increase, the higher are the advantages in using GPU. The maximum 
improvement of the GPUs is retrieved when the wright amount of job is sent to these units. A 
good practice in GPU coding is design the algorithm to create a number of threads between 
10,000 and 30,000 (approximated), saving latency and memory transfer time. 
The results presented here are only preliminaries demonstrating the potential that can be 
achieved when GPU technology is applied. As the algorithms becomes more optimized, it is 
expected a small variation in the differences of speed (could be lower), yet it is expected that 
the GPU version could at least save time in two or three order of magnitude.   
The optimizations required in this VolArea GPU version are essentially in order to solve 
portability and compatibility issues. In the development of this algorithm, it was included 
some features that are exclusive of the newest models associated with the CUDA Compute 
Capability (CCC) version number (https://developer.nvidia.com/cuda-gpus). The algorithm 
was developed based on a model presenting a CCC number 3.0 or higher, which allows the 
appliance of the atomic operations and parallel reductions. For a general usage of this 
version, these operations must be redesigned or even replaced to a self-developed GPU 
counter and sum operator. It is also intended the realization of a broader benchmark test to 
analyze the behavior of this algorithm is a larger set of structures and GPU models.      
 
3.4.1.3. Conclusion 
 
GPUs technology is been widely applied for molecular studies purposes, returning good 
results, especially when the costs/processing potential are compared with CPU or CPU 
clusters. The adaptation of VolArea volume algorithm to this new technology revealed a great 
potential in terms of computational time gains. The preliminaries results shown that it is 
possible to improve the computational time more than two orders of magnitude by applying 
GPUs. Despite the good results, more work is required in order to guarantee the proper 
portability and compatibility between different GPU devices and different operating systems.  
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3.5. CompASM 
 
The study of protein interactions, either with other proteins or with smaller molecules, can 
be a difficult and very demanding operation mainly due to the amount of information involved. 
The study of protein-protein interface surfaces, where the main purpose is to analyze the 
importance of the interfacial residues in the stabilization of the corresponding protein-protein 
complexes, is also characterized by the exponential growth of files and information. This 
analysis can be performed by the Computational Alanine Scanning Mutagenesis 
(CompASM) software developed in this work. We introduce here a package that drives the 
user through the main steps of the ASM algorithm: the ligand/receptor selection, the 
selection of the residues to mutate, the performance of molecular simulations and the 
visualization of the final results in a very intuitive and informative way. This protocol is based 
on Molecular Mechanics/ Poisson-Boltzmann Surface Area (MMPBSA) scripts that evaluates 
the difference between the Gibbs free energy of the wild and the mutated complexes. In 
order to provide the accuracy expected in this kind of calculation allied to the visual analysis 
mostly required in these studies, this tool requires also two other software programs already 
in the literature, Visual Molecular Dynamics (VMD) and the molecular dynamics package 
AMBER.  
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Article IV 
 
“CompASM: an Amber-VMD alanine scanning mutagenesis plug-in“ 
 
Ribeiro J.,Cerqueira N.M.F.S.A., Moreira I.S.,Fernandes P.A., Ramos M. J. 
Theor Chem Acc 131:1271-1278, 2012. 
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3.6. CompASM - an Amber-VMD Alanine Scanning Mutagenesis  
plug-in. 
J. V.  Ribeiro, N.M.F.S.A. Cerqueira, I.S. Moreira, P.A Fernandes, M.J. and Ramos 
REQUIMTE , Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do 
Porto, Rua Campo Alegre s/n , 4169-007 Porto, Portugal. 
3.6.1. Abstract 
Alanine scanning mutagenesis (ASM) of protein–protein interfacial residues is a popular 
means to understand the structural and energetic characteristics of hot-spots in protein 
complexes.  In this work, we present a computational approach that allows performing such 
type of analysis based on the Molecular Mechanics/Poisson-Boltzmann Surface Area 
(MMPBSA) method. This computational approach has been used largely in the past and has 
proven to give reliable results in a wide range of complexes.  However, the sequential 
preparation and manual submission of dozens of files has been often a major obstacle in 
using it.  To overcome these limitations, and turn this approach user-friendly, we have 
designed the plug-in CompASM (Computational Alanine Scanning Mutagenesis). This 
software has an easy-to-use graphical interface to prepare the input files, run the calculations 
and analyze the final results. CompASM was built in TCL/TK programming language to be 
included in VMD as a plug-in. The CompASM package is distributed as an independent 
platform, with script code under the GNU Public License from 
http://compbiochem.org/Software/compasm/Home.html. 
 
Keywords: Protein-protein interactions; Amber; VMD; MMPBSA; software. 
3.6.2. Introduction 
The association of proteins and the way they bind are a crucial topic in the study of living 
organisms. This importance stems from the fact that protein-protein interactions play a 
crucial role in the molecular recognition and cellular function. Mapping these interactions at 
the interface and revealing the key-stone residues, will provide important insight on how 
these structures combine and how it is possible to manage them, as well as improving or 
inhibiting their association 152 153.  
One of the key features of these protein-protein interfaces is their sensitivity to mutations. 
This means that if we mutate a key interface residue by a residue alanine, there will be a 
significant variation in the protein-protein complex binding or association free energy. It has 
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been defined in the literature that if the increase in the binding free energy is above 4 
kcal/mol, then the mutated residue is extremely important and it is called a hot-spot; if the 
energy increase upon mutation is between 2 and 4 kcal/mol, then this residue is relatively 
important for the protein-protein association and it is denominated a warm-spot and, finally, if 
the mutations originate a binding free energy variation below 2 kcal/mol, then the residue is 
not particularly relevant for the interaction and it is termed a null-spot27,154,155. 
Moreira et al27 have developed a protocol (schematized in Figure 29), with low 
computational cost and high success rate that reproduces the quantitative free energy 
differences obtained from experimental mutagenesis procedures. This computational 
approach is transferable to any macromolecular complex and is a predictive model capable 
of anticipating the experimental results of mutagenesis, thus capable of guiding new 
experimental investigations. It is based on the all-atom methodology MMPBSA (Molecular 
Mechanics/Poisson-Boltzmann Surface Area)29 to probe protein–protein interactions by 
calculating free energies combining molecular mechanics and a continuum solvent. 
There are several web servers already available to compute this protein-protein 
interaction156.  Despite the large variety of available possibilities to study this kind of 
interactions, our method still proved to be better from the point of view of returning 
quantitative values of the binding free energy differences with molecular dynamics as the 
sampling method. The features contrast with the qualitative values and the analysis of only a 
few structures of other methods available.  At the end of the Results section, values from 
other approaches obtained for our case studies are also presented for comparison.  
 
3.6.3. Methodology 
The first stage of CompASM involves the relaxation and equilibration of the wild-type 
complex that is being analyzed. This can be accomplished by a minimization procedure only 
or by a molecular dynamics simulation in a continuum medium, using the Generalized Born 
model. Subsequently, only the relaxed wild-type complex is divided in several alanine 
mutated complexes that were previously defined by the user, depending on the study that is 
intended to be performed. To the wild-type and mutated complexes it is then applied the 
MMPBSA script to calculate the respective binding free energy differences. 
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Figure 29: General algorithm of the CompASM procedure 27. 
 
To generate the structure of the mutant complex, a simple truncation of the mutated side 
chain is carried out, replacing carbon atom Cγ with a hydrogen atom, and setting the Cβ−H 
bond direction to that of the former Cβ−Cγ. The corresponding binding free energy can be 
calculated using the thermodynamic cycle described in Methods section (2.1.4.1 Molecular 
Dynamics/Poisson-Boltzmann Surface Area). 
For the energy calculations, CompASM attributes specific values to three internal 
dielectric constant values, which depend exclusively on the type of amino acid that is 
mutated. Therefore, for the charged amino acids (aspartic acid, glutamic acid, lysine, 
arginine, and histidine) a constant of 4 should be used, for the remaining polar residues 
(aspargine, glutamine, cysteine, tyrosine, serine, and threonine) not ionized at physiological 
pH the internal dielectric constant should be 3, and for the nonpolar amino acids (valine, 
leucine, isoleucine, phenylalanine, methionine, and tryptophan) the internal dielectric 
constant should be 227. The different internal dielectric constants account for the different 
degree of relaxation of the interface when different types of amino acids are mutated for 
alanine; the stronger the interactions these amino acids establish, the more extensive the 
relaxation should be, and the greater the internal dielectric constant value must be to mimic 
these effects. 
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However, for the sake of flexibility, in order to allow the user to set other values that he 
might see fit to the dielectric constants, we have added a feature in which the values of any 
number of dielectric constants can be changed from the default ones mentioned above or 
even added if necessary. This introduces flexibility to the plug-in and allows the user to 
improve the quality of the results, if considered necessary. 
 
The nonpolar contribution to solvation free energy due to van der Waals interactions 
between the solute and the solvent and cavity formation, was modeled as a term that is 
dependent on the solvent-accessible surface area of the molecule. It was estimated using 
empirical relation (16), 
 
where A is the solvent-accessible surface area that was estimated using the molsurf 
program, which is based on the idea primarily developed by Michael Connolly. Constants α 
and β are empirical, taking the values 0.005%42 kcal Å-2 mol-1 and 0.92 kcal mol-1, 
respectively. The entropy term, obtained as the sum of translational, rotational, and 
vibrational components, was not calculated because it was assumed, on the basis of 
previous work 55,56, that its contribution to ΔΔGbinding is negligible. 
The calculation of ΔΔGbinding is achieved applying several modules of the AMBER program 
30, and despite the apparent simplicity, this kind of study can easily become cumbersome. 
Beyond the repetitive tasks, such as the generation of mutation structures and the input for 
the MMPBSA 56 calculation, the handling of a large amount of files can be a tricky job. 
Regarding these difficulties and combining the visual facilities provided by Visual Molecular 
Dynamics (VMD)31 with the extremely intuitive Graphical User Interface (GUI) and the 
AMBER molecular dynamics calculations, we propose a new VMD-AMBER plug-in, named 
CompASM, which allows even the non-expert user to perform easily Alanine Scanning 
Mutagenesis calculations.    
3.6.4. Software Description  
CompASM is a versatile tool created to study protein-protein interfaces, allowing the user 
to skip the repetitive task of creating input files and generating all necessary structures, as 
well as providing new options and procedures to perform a computational Alanine Scanning 
Mutagenesis experiment. The input file is based on an AMBER-format file. To maintain the 
functionality in almost all situations, we have divided the software in two main structures: a 
VMD plug-in GUI and an independent CORE.     
 ∆!!"!#"$%& = !" + !! (16)  
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The CompASM GUI was designed to drive the user through the different steps of ASM, 
allowing simultaneously all the freedom needed to treat all kind of structures that require 
different specifications. Beyond the ligand/receptor differentiation and mutation selection, this 
GUI allows the user to exclude or include non-protein structures (known as heteroatoms) as 
well as to insert their parameterisation files (.mol2 and/or .frcmod files). Another facility 
presented by CompASM GUI is the molecular minimisation/dynamics simulation set-up tab. 
Here, the user can set all variables to the values needed to submit a molecular dynamics 
simulation or just a minimization to AMBER. The user can add more variables directly in the 
input file following the instructions that pop up as one proceeds in the calculation. Another 
useful tool is the mutation selection by Non-Solvent Contact Area (NSCA-explained 
schematically in Figure 30) based selection (Figure 30).  
 
 
Figure 30:Scheme representing the Non-Solvent Contact Area (NSCA). This area intends to represent by which amount 
each residue is buried in the protein surface. All surface areas are evaluated by the “sasa measure” command present 
in the Visual Molecular Dynamics (VMD) software. 
This is based on a “sasa measure” VMD command, and the residue is selected if the area 
that is in contact with another structure is larger than 40 Å2 (more detail in supporting 
information). The final results are visualized in the VMD graphics window, using the same 
colour scheme of the summary and the detailed tables in the GUI. 
The CompASM CORE is an independent set of procedures that load the structure, and 
perform the algorithm proposed by Moreira et al. 27 This CORE handles the files 
organization, performs the MMPBSA calculations and returns an output file (ASM.out) with all 
the information necessary to evaluate the final results. To improve the speed and make the 
best use of the computational resources, we parallelized the slower procedure, the MMPBSA 
calculation, running each independent calculation in different CPU cores. In the CORE’s 
procedures, the molecular dynamics simulation is performed in sets of 1/10 of the total time 
requested by the user. In each set, the program checks if the coordinates from the structure 
(backbone only) are stabilized, evaluating several parameters of the linear regression of the 
Root Mean Square Deviation (RMSD) calculated by the ptraj AMBER tool. The simulation is 
considered stabilised if the slope of the straight, the standard deviation and the correlation 
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factor are in agreement with the values set by the user. For more information, please see the 
supporting information of this document. This software was developed in TCL/TK as the 
programming language, and it is available for the Amber8 and 9 versions, requiring the 
DELPHI package 51-53. The application of this software using higher versions of Amber is not 
presently possible, only due to the inexistence of the DELPHI package in the MMPBSA 
protocol (i.e. not available in the Amber 10 package). 
3.6.5. Results 
The data resulting from CompASM is displayed in a simplified table and in a more detailed 
table are displayed all the values obtained from the MMPBSA calculation, including the 
NSCA values. All this data can be analysed interactively in a VMD window, colouring the 
residue depending on the obtained score. Figure 31 shows the results obtained from 
CompASM concerning the protein-protein interface study of immunoglobulin complexed with 
an egg lysozyme, as an example. 
 
 
Figure 31: Results of the protein-protein interface study of immunoglobulin complexed with an egg lysozyme (detailed 
results in supporting information).  
In this section we describe the validation process that was used to evaluate the 
performance of the CompASM software in the determination of the hot, warm and null-spots 
of three different protein-protein complexes. The results of this validation process are shown 
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in Table II. The structures analyzed are immunoglobulin complexed with an egg lysozyme 
(1VFB)139; complexes that mediate bacterial cell division (1F47)157 and human 
immunoglobulin IgG complexed with the C2 fragment of streptococcal protein G (1FCC)158. 
Table II shows the values of NCSA, the experimental value of ΔΔGbinding of each mutation 
and the ΔΔGbinding evaluated by CompASM. All calculations involved molecular dynamics 
simulations using the default values of the CompASM GUI (Figure 31), and modifying only 
the MMPBSA frequency to achieve low standard deviation values. In the MMPBSA 
calculations of the 1VFB and 1F47 proteins, 50 structures were used, from the fourth and 
fifth nanosecond respectively of the simulation, and in the case of the 1FCC corresponding 
protein, 100 structures were used from the forth nanosecond. These same structures were 
also analyzed using well known web servers available, and the positive predictive value or 
specificity P (equation 17), true positive rate or sensitivity R (equation 18) and the F-measure 
test accuracy F1 (equation 19) values were calculated and shown in Table III. 
 
 
In equations (17), (18) and (19), TP corresponds to the correct computational prediction of 
the number of hot-spots (TP-true positive), i.e. when these residues are experimentally 
classified as hot-spots; FP corresponds to the number of computationally predicted hot-spots 
when these residues are experimentally classified as null-spots (FP-false positive); and 
finally FN corresponds to the number of computationally predicted null-spots when these 
residues are experimentally classified as hot-spots (FN-false negative). Therefore, the closer 
the values are to 100 the better they are, meaning in this case that the software is capable to 
predict correctly the numbers of hot-spots and null-spots.  
To compare our software to those from webservers already available, we tested the same 
mutations in the proteins analyzed above using the following softwares: ISIS159; Promate160; 
Robetta161; K-FC2A and B 162 and HotPoint163.  
Tables II and III demonstrate that the values resulting from CompASM are in the same 
range of those provided by experimental means, i.e. the CompASM software was able to 
detect all the hot-spots. This software was also sensitive enough to detect and to distinguish 
most warm- and null-spots. The results are very close to those obtained by Moreira et al. 27 in 
which the methodology of CompASM was based on. The small differences result from the 
 ! = !"!" + !"!! (17)  
 ! = !"!" + !"! (18)  
 !1 = !"#! + !!! (19)  
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differences in the structures retrieved from the MD simulations and submitted to the 
MMPBSA calculations. CompASM has its own algorithm, which is used to control the 
molecular dynamics simulations. Once all the criteria are achieved, which the user can either 
set him/herself or accept the default, the MD simulation is stopped and the MMPBSA 
protocol starts. This algorithm is very useful because it makes the process straightforward 
and minimizes the computation time. Simultaneously, it allows the process to be 
reproducible. This makes it very handy not only for non-expert users, but also for more 
advanced users that can modify the criteria used in the CompASM GUI. 
 
Table II - Results originated by CompASM. The Non-Solvent Contacting Area (NSCA) is calculated by the CompASM 
program. 
 
 
Table II shows the number of true positive (TP), true negative (TN), false positive (FP) and 
false negative (FN) values, as well as the accuracy of the different tested software. 
 
MMPBSA Experimental
Freq ΔΔGexp5(kcal/mol) ΔΔGComASM5 (kcal/mol) STDV EXP CompASM
1VFB 67 TYR_32_A 65.00 Polar 1.30 3.20 0.89 Null:Spot Warm:Spot
1VFB 67 TYR_49_A 20.60 Polar 0.80 0.39 0.89 Null:Spot Null:Spot
1VFB 67 TYR_50_A 37.80 Polar 0.40 2.40 0.91 Null:Spot Warm:Spot
1VFB 67 THR_53_A 15.00 Polar B0.23 0.26 0.87 Null:Spot Null:Spot
1VFB 67 TRP_92_A 48.30 Nonpolar 1.71 1.71 0.94 Null:Spot Null:Spot
1VFB 67 SER_93_A 26.40 Polar 0.11 B0.10 0.90 Null:Spot Null:Spot
1VFB 67 TYR_32_B 30.00 Polar 0.50 1.23 0.88 Null:Spot Null:Spot
1VFB 67 TRP_52_B 45.90 Nonpolar 1.23 3.90 0.89 Null:Spot Warm:Spot
1VFB 67 ASP_54_B 38.00 Charged 1.95 2.55 0.94 Null:Spot Hot:Spot
1VFB 67 ARG_99_B 42.80 Charged 0.47 0.86 0.93 Null:Spot Null:Spot
1VFB 67 ASP_100_B 66.70 Charged 3.10 4.47 0.92 Warm:Spot Hot:Spot
1VFB 67 TYR_101_B 70.80 Polar 4.00 4.04 0.91 Hot:Spot Hot:Spot
1VFB 67 ASP_18_C 27.90 Charged 0.30 0.51 0.97 Null:Spot Null:Spot
1VFB 67 ASN_19_C 69.00 Polar 0.40 0.78 0.89 Null:Spot Null:Spot
1VFB 67 TYR_23_C 12.10 Polar 0.80 2.84 0.91 Null:Spot Warm:Spot
1VFB 67 SER_24_C 52.90 Polar 0.70 2.12 0.91 Null:Spot Warm:Spot
1VFB 67 LYS_116_C 57.60 Charged 0.70 3.06 0.94 Null:Spot Warm:Spot
1VFB 67 THR_118_C 42.70 Polar 0.80 0.19 0.91 Null:Spot Null:Spot
1VFB 67 ASP_119_C 43.70 Charged 1.00 3.48 0.96 Null:Spot Warm:Spot
1VFB 67 VAL_120_C 9.70 Nonpolar 0.90 B0.39 0.92 Null:Spot Null:Spot
1VFB 67 GLN_121_C 108.10 Polar 2.90 2.53 0.91 Warm:Spot Warm:Spot
1VFB 67 ILE_124_C 28.70 Nonpolar 1.20 0.09 0.92 Null:Spot Null:Spot
1VFB 67 ARG_125_C 48.80 Charged 1.80 3.21 0.93 Null:Spot Warm:Spot
1VFB 67 LEU_129_C 23.60 Nonpolar 0.20 B9.93 0.93 Null:Spot Null:Spot
1F47 67 ASP_4_A 43.20 Charged 0.69 B1.60 0.8 Null:Spot Null:Spot
1F47 67 TYR_5_A 63.30 Polar 0.86 4.21 0.74 Null:Spot Hot:Spot
1F47 67 LEU_6_A 81.70 Nonpolar 0.92 1.59 0.78 Null:Spot Null:Spot
1F47 67 ASP_7_A 22.30 Charged 1.73 B0.46 0.78 Null:Spot Null:Spot
1F47 67 ILE_8_A 50.70 Nonpolar 2.50 3.12 0.77 Warm:Spot Warm:Spot
1F47 67 PHE_11_A 77.00 Nonpolar 2.44 3.60 0.79 Warm:Spot Warm:Spot
1F47 67 LEU_12_A 53.10 Nonpolar 2.29 2.21 0.79 Warm:Spot Warm:Spot
1FCC 35 GLU_27_C 45.80 Charged 4.90 10.91 1.17 Hot:Spot Hot:Spot
1FCC 35 LYS_28_C 122.30 Charged 1.30 2.40 1.22 Null:Spot Warm:Spot
1FCC 35 LYS_31_C 56.10 Charged 3.50 4.83 1.20 Warm:Spot Hot:Spot
1FCC 35 ASN_35_C 61.80 Polar 2.40 0.95 1.12 Warm:Spot Null:Spot
1FCC 35 ASP_40_C 44.20 Charged 0.30 0.49 1.23 Null:Spot Null:Spot
1FCC 35 GLU_42_C 26.00 Charged 0.40 0.34 1.23 Null:Spot Null:Spot
1FCC 35 TRP_43_C 37.80 Nonpolar 3.80 B0.13 1.09 Warm:Spot Null:Spot
Protein
ComPASM SCORES
Mutation NSCA5(Å2) Residue5Type
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Table III - Comparison of the values obtained using CompASM with those that result from the software/servers 
available. TP= true positive; TN= true negative; FN= false negative; FP= false negative, R= positive predictive; P= 
negative predictive and F1= F-measure. 
 
 
Looking at the data resulting from CompASM, we can notice only 2 false negative values. 
There are, however, 11 false positives. In the majority of the complexes studied, an analysis 
of the dominant interactions suggests that van der Waals interactions and hydrophobic 
effects provide a reasonable basis for understanding binding affinities. In fact, the breakdown 
of equation (12) for all the cases studied with CompASM, shows that the DDEvdw values are 
almost all positive indicating that the van der Waals interactions are favourable to complex 
binding, and that alanine mutation of the residues diminishes the vdW contacts at the 
interfaces. This is explained by the hydrophobic character of the interfaces.  
To further examine the reliability and usefulness of CompASM, we have compared our 
predictions to the predictions of some of the more popular softwares that are available 
nowadays. The results are presented in Table III pointing to the fact that the methods 
Robetta, KFC2-A, KFC2-B, HotPoint and CompASM have similar performances, with the 
latter giving slightly better values. However, in a subsequent work 164, we provide a full study 
documenting the results obtained with CompASM based on a large number of structures, 
which  points out to its good performance generating the better values amongst other 
methods. 
We notice that only two of the above mentioned approaches, ours and Robetta’s, provide 
quantitative values, which can be fully compared to the experimental ones, as opposed to 
qualitative values that classify the mutations between hot, warm and null spots only. 
However, in order to compare the results obtained with CompASM to the values returned by 
other softwares, we translated our values to the binominal qualitative classification (null and 
hot-spot) adopted by the tested softwares, which classify the residues in null-spots if the 
ΔΔG values are below 2 kcal/mol and hot-spots if the ΔΔG values are higher than 2 kcal/mol.  
CompASM returns a value close to 100 (80) for the values of R (hot-spots prediction over 
false negatives). However, as CompASM is a software with which we can obtain quantitative 
values, we know directly how close is the residue to be a null or a hot-spot by comparing the 
obtained ΔΔG with the reference barriers of 2 and 4 kcal/mol, respectively.  
 
Abrev. ISIS Promate ROBETTA KFC2-A KFC2-B HotPoint CompASM
TP 1 0 7 5 6 6 8
TN 26 25 21 25 23 20 17
FP 2 3 7 3 5 8 11
FN 9 10 3 5 4 4 2
R 10 0 70 50 60 60 80
P 33 0 50 63 55 43 42
F1 15 0 58 56 57 50 55
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3.6.6. Conclusions 
Computational alanine scanning mutagenesis 27has proven to be an accurate means of 
detecting the residues that play an important role in protein-protein interfaces (hot-spots). 
Here, we present a VMD plug-in, CompASM, which facilitates the application of this 
approach thus simplifying the study of protein interfaces. CompASM guides the user through 
all ASM steps, from the ligand/receptor selection to the molecular dynamics simulation, and 
provides the visualization of the final results in a VMD window. This program can run either in 
local machines or in a cluster (multicomputer system). The GUI package is multiplatform and 
the CORE package works in a UNIX system (Mac OS and Linux).  
The CompASM package is distributed as an independent platform, with script code under the 
GNU Public License from http://compbiochem.org/Software/compasm/Home.html. 
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4. General Conclusions 
The main purpose of the present work was to develop new bioinformatics tools to improve 
the Computer-Aided Drug Design process, reducing in this way the time and costs 
associated with the early steps of the drug development. The difficulties in applying these 
computational techniques are related with two major aspects: the numerous input 
files/commands preparations for a single job submission and the amount of information that 
is necessary to deal with in order to prepare these files and read the output results. These 
drawbacks can be overcome by expert users, specially by those with programming/scripting 
skills. In this work we presented four different tools aimed at calculating different properties 
or structural features, directed at being used by every type of users, even by the non-expert 
users.  
In spite of the differences within the objectives of the developed tools, the guide lines 
behind them were basically the same. All developed software was based on the assumptions 
of being user-friendly, dismissing pre-knowledge from the user and requiring only a few clicks 
to perform the calculation; allowing a more sophisticated usage from experienced users; 
providing new algorithms capable of performing fast calculations and if possible, parallelizing 
the routines in order to return the maximum results from the available hardware. In the end, 
the final results must be visualized both in an intuitive graphical user interface and in the 
molecular visualizer VMD. 
The first software to be developed was vsLab, which automatized the process of 
molecular docking, giving to the user the opportunity to perform molecular docking and/or 
virtual screening requiring only a small amount of clicks. Using vsLab is possible to perform 
the docking of a large set of ligands in the same protein and to visualize in the same program 
the final results. The inspection of the binding modes/positions can be performed by the 
analysis of the results table that presents the free energy and inhibition constant values 
calculated by AutoDock and simultaneously, the user can compare these values against the 
spatial arrangement of the complex (ligand and receptor) in the visualization window of VMD. 
Taking into account this visual feature of the VMD software and the vast range of 
possibilities to select atoms and structure components (e.g. residues), we developed Chem-
Path-Tracker. Rather than calculate a property, this software was developed to highlight 
“paths” between selected points, revealing cluster of atoms/residues that can constitute a 
chemical motif. For instance, this software turns easier the evaluation and the arrangement 
of the binding site revealing possibly existing networks of residues surrounding the ligand; 
the residues’ spatial sequence, forming cation-π interactions; the residues that interact with 
water in a water tunnel and the residues that contribute to the proton/electron transfer inside 
an enzyme. Again, contemplating only a few selections and parameters it is possible to 
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analyze a large number of pair-distances, revealing a wide range of possible interactions that 
would be very difficult to deduct manually. 
Another developed plug-in dedicated to the structure analysis is VolArea. This tool was 
developed to calculate two different structural features: residues’ exposed surfaces and the 
structural and empty volumes (e.g. cavities). VolArea revealed itself to be very useful and 
user-friendly when large surfaces need to be analyzed, calculating the contribution of each 
residue to the total surface. This usefulness is also linked to the volume calculation, where 
only the fraction of the structure that needs to be calculated is necessary to delimitate. The 
surface value is calculated using the VMD31 native command “measure sasa”, while the 
volume algorithm was developed from scratch. This algorithm was designed to achieve a 
good compromise between accuracy and computational efficiency, which is why it was 
parallelized in order to use all the CPU available. Lately, a CUDA149 version was developed 
to retrieve the maximum potential from the GPUs. These devices are well suited to solve 
problems containing variables with a high degree of independency, returning excellent 
results when transcribed to CUDA. Applying this new technology, the VolArea volume 
algorithm has shown a speed up of nearly 45 times. Despite the promising results, this 
algorithm requires special attention to the efficiency and consistence of the values. The 
existence of different devices and architectures raises portability and compatibility issues.         
The last software to be presented in this thesis, named CompASM, was developed to 
guide the user through the steps needed for a Computational Alanine Scanning Mutagenesis 
calculation. Like vsLab, CompASM stands as a simplifying tool to perform complex and 
laborious calculations reflecting a fast learning process and reduced efforts from the user. 
Here it is possible to mutate large protein interfaces in order to evaluate the impact of the 
interacting residues in the free energy of the complex, determining their importance to the 
binding of the proteins. In terms of conception of the software, it encompasses many 
improvements in terms of programming skills and conceptual developments. These thoughts 
are reflected in a very agile interface that allows the user to perform a variety of operations, 
from the simple selection of ligands and receptors, to the inclusion and exclusion of residues, 
change/include molecular dynamics simulation parameters. The visualization of the final 
results was developed to make this GUI fully interactive. CompASM is composed by two 
independent packages, the GUI and CORE packages, in which the latter deals with all file 
management and all calculations using the AMBER30 molecular package. The computational 
efficiency of the MMPBSA calculations was improved assigning each MMPBSA calculation to 
each CPU core. For instance, if the machine has an 8 core processor, than it is possible to 
calculate 8 mutations and respective ΔΔGbinding simultaneously. The independency of the GUI 
and CORE packages allows their use in different environments such as a regular Desktop or 
   FCUP 
COMPUTER-AIDED DRUG DESIGN - Lead Discovery 
118 
 
Laptop to perform the results inspection using the GUI and run all heavy calculations in a 
Computer Cluster using only the CORE package.    
Like any other software, the tools described in this thesis also require improvements and 
updates. For instance, vsLab is now on version 1.3, where several bugs were fixed and new 
options were included such as the possibility to change the pdbqt files before the AutoDock26 
calculations. The usage of a purchasable molecular package by CompASM requires the 
proper modification of the program in order to use an open source software, for instance 
NAMD165, which also implies the development of a substitute routine of the DELPHI 
package51-53 to calculate the electrostatic solvation free energy. As mentioned before, the 
development of the CUDA version of the VolArea plug-in revealed promising results, but still 
requires more work in order to ensure the proper portability and compatibility between 
devices. Regarding Chem-Path-Tracker, in spite of be the most recent software, the 
development of a mathematical expression in order to imprint a chemical sense to the 
distance evaluation routine could be important for the improvement of this tool. 
The described tools are freely available for downloading in their websites:  
vslab: http://www.fc.up.pt/pessoas/nscerque/vsLab/vLab/HomePage.html;  
Chem-Path-Tracker: http://www2.fc.up.pt/PortoBioComp/database/doku.php?id=chem-path-
tracker; 
 VolArea: http://www.fc.up.pt/portobiocomp/Software/Volarea/Home.html; and 
CompASM: http://www.fc.up.pt/portobiocomp/Software/compasm/Home.html. 
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